{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,19]],"date-time":"2026-11-19T22:21:54Z","timestamp":1795126914526,"version":"4.10.3"},"reference-count":385,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T00:00:00Z","timestamp":1787011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T00:00:00Z","timestamp":1787011200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sig Transduct Target Ther"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Macrophages have emerged as promising candidates for cell-based immunotherapies due to their intrinsic plasticity, tissue-infiltrating capabilities, and central roles in orchestrating immune responses. Their phenotypic and functional diversity within tissues and the tumor microenvironment has driven interest in harnessing these cells for therapeutic purposes. Integrating recent knowledge in signaling cascades balancing the activity of macrophages in combination with genetic engineering have enabled the development of macrophages with improved functions, including the introduction of synthetic receptors such as chimeric antigen receptors (CARs). These superior macrophages orchestrate innate immune activity with antigen-specific targeting, offering distinct advantages over conventional CAR-T and CAR-NK cell therapies, especially in solid malignancies. Emerging preclinical and early clinical data support the feasibility, safety, and therapeutic potential of macrophage-based strategies. However, successful clinical translation requires overcoming key challenges in standardization, scalable manufacturing and regulatory compliance of cell products. This review integrates current knowledge in the diversity of macrophage signaling which feeds into engineering techniques, therapeutic applications, and manufacturing innovations. Leveraging concepts of macrophage tissue plasticity highlights the potential of macrophages as next-generation cell therapeutics with broad potential in oncology and beyond, bridging fundamental immunology with translational medicine. Continued interdisciplinary research will accelerate clinical adoption and expand indications across diseases.<\/jats:p>","DOI":"10.1038\/s41392-026-02907-x","type":"journal-article","created":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T00:02:49Z","timestamp":1787011369000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Harnessing macrophage signaling pathways and scalable engineering for next-generation immunotherapies"],"prefix":"10.1038","volume":"11","author":[{"given":"Daniela","family":"Paasch","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kathrin","family":"Haake","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chloe","family":"Kan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cristiana","family":"Ulpiano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eirini","family":"Nikolouli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mi-Sun","family":"Jang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark-Christian","family":"Klassen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Epstein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5701-3628","authenticated-orcid":false,"given":"Ryohichi","family":"Sugimura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4245-1497","authenticated-orcid":false,"given":"Nico","family":"Lachmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,8,18]]},"reference":[{"key":"2907_CR1","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1016\/j.immuni.2014.06.013","volume":"41","author":"S Epelman","year":"2014","unstructured":"Epelman, S., Lavine, K. J. & Randolph, G. J. Origin and functions of tissue macrophages. Immunity 41, 21\u201335 (2014).","journal-title":"Immunity"},{"key":"2907_CR2","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/978-1-4419-0901-5_1","volume":"653","author":"S Mukhopadhyay","year":"2009","unstructured":"Mukhopadhyay, S., Pl\u00fcddemann, A. & Gordon, S. Macrophage pattern recognition receptors in immunity, homeostasis and self tolerance. Adv. Exp. Med. Biol. 653, 1\u201314 (2009).","journal-title":"Adv. Exp. Med. Biol."},{"key":"2907_CR3","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.abn1128","volume":"14","author":"C Chen","year":"2022","unstructured":"Chen, C. et al. Intracavity generation of glioma stem cell-specific CAR macrophages primes locoregional immunity for postoperative glioblastoma therapy. Sci. Transl. Med. 14, eabn1128 (2022).","journal-title":"Sci. Transl. Med."},{"key":"2907_CR4","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1038\/s41577-023-00848-y","volume":"23","author":"E Mass","year":"2023","unstructured":"Mass, E., Nimmerjahn, F., Kierdorf, K. & Schlitzer, A. Tissue-specific macrophages: how they develop and choreograph tissue biology. Nat. Rev. Immunol. 23, 563\u2013579 (2023).","journal-title":"Nat. Rev. Immunol."},{"key":"2907_CR5","doi-asserted-by":"publisher","first-page":"4259","DOI":"10.1016\/j.cell.2022.10.007","volume":"185","author":"MD Park","year":"2022","unstructured":"Park, M. D., Silvin, A., Ginhoux, F. & Merad, M. Macrophages in health and disease. Cell 185, 4259\u20134279 (2022).","journal-title":"Cell"},{"key":"2907_CR6","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1084\/jem.128.3.415","volume":"128","author":"R van Furth","year":"1968","unstructured":"van Furth, R. & Cohn, Z. A. The origin and kinetics of mononuclear phagocytes. J. Exp. Med. 128, 415\u2013435 (1968).","journal-title":"J. Exp. Med."},{"key":"2907_CR7","first-page":"845","volume":"46","author":"R van Furth","year":"1972","unstructured":"van Furth, R. et al. The mononuclear phagocyte system: a new classification of macrophages, monocytes, and their precursor cells. Bull. World Health Organ. 46, 845\u2013852 (1972).","journal-title":"Bull. World Health Organ."},{"key":"2907_CR8","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1002\/jlb.45.2.87","volume":"45","author":"K Takahashi","year":"1989","unstructured":"Takahashi, K., Yamamura, F. & Naito, M. Differentiation, maturation, and proliferation of macrophages in the mouse yolk sac: a light-microscopic, enzyme-cytochemical, immunohistochemical, and ultrastructural study. J. Leukoc. Biol. 45, 87\u201396 (1989).","journal-title":"J. Leukoc. Biol."},{"key":"2907_CR9","doi-asserted-by":"publisher","first-page":"842","DOI":"10.1182\/blood.V39.6.842.842","volume":"39","author":"MJ Cline","year":"1972","unstructured":"Cline, M. J. & Moore, M. A. Embryonic origin of the mouse macrophage. Blood 39, 842\u2013849 (1972).","journal-title":"Blood"},{"key":"2907_CR10","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1016\/S0165-3806(99)00113-3","volume":"117","author":"F Alliot","year":"1999","unstructured":"Alliot, F., Godin, I. & Pessac, B. Microglia derive from progenitors, originating from the yolk sac, and which proliferate in the brain. Brain Res. Dev. Brain Res. 117, 145\u2013152 (1999).","journal-title":"Brain Res. Dev. Brain Res."},{"key":"2907_CR11","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1126\/science.1219179","volume":"336","author":"C Schulz","year":"2012","unstructured":"Schulz, C. et al. A lineage of myeloid cells independent of Myb and hematopoietic stem cells. Science 336, 86\u201390 (2012).","journal-title":"Science"},{"key":"2907_CR12","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1016\/j.immuni.2012.12.001","volume":"38","author":"S Yona","year":"2013","unstructured":"Yona, S. et al. Fate mapping reveals origins and dynamics of monocytes and tissue macrophages under homeostasis. Immunity 38, 79\u201391 (2013).","journal-title":"Immunity"},{"key":"2907_CR13","doi-asserted-by":"publisher","first-page":"792","DOI":"10.1016\/j.immuni.2013.04.004","volume":"38","author":"D Hashimoto","year":"2013","unstructured":"Hashimoto, D. et al. Tissue-resident macrophages self-maintain locally throughout adult life with minimal contribution from circulating monocytes. Immunity 38, 792\u2013804 (2013).","journal-title":"Immunity"},{"key":"2907_CR14","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1038\/ni.3341","volume":"17","author":"EG Perdiguero","year":"2016","unstructured":"Perdiguero, E. G. & Geissmann, F. The development and maintenance of resident macrophages. Nat. Immunol. 17, 2\u20138 (2016).","journal-title":"Nat. Immunol."},{"key":"2907_CR15","doi-asserted-by":"crossref","unstructured":"Mass, E. et al. Specification of tissue-resident macrophages during organogenesis. Science 353, aaf4238 (2016).","DOI":"10.1126\/science.aaf4238"},{"key":"2907_CR16","doi-asserted-by":"publisher","first-page":"1135","DOI":"10.1038\/ni852","volume":"3","author":"M Merad","year":"2002","unstructured":"Merad, M. et al. Langerhans cells renew in the skin throughout life under steady-state conditions. Nat. Immunol. 3, 1135\u20131141 (2002).","journal-title":"Nat. Immunol."},{"key":"2907_CR17","doi-asserted-by":"publisher","first-page":"1538","DOI":"10.1038\/nn2014","volume":"10","author":"B Ajami","year":"2007","unstructured":"Ajami, B., Bennett, J. L., Krieger, C., Tetzlaff, W. & Rossi, F. M. V. Local self-renewal can sustain CNS microglia maintenance and function throughout adult life. Nat. Neurosci. 10, 1538\u20131543 (2007).","journal-title":"Nat. Neurosci."},{"key":"2907_CR18","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1038\/s41593-020-0585-y","volume":"23","author":"Y Werner","year":"2020","unstructured":"Werner, Y. et al. Cxcr4 distinguishes HSC-derived monocytes from microglia and reveals monocyte immune responses to experimental stroke. Nat. Neurosci. 23, 351\u2013362 (2020).","journal-title":"Nat. Neurosci."},{"key":"2907_CR19","doi-asserted-by":"publisher","first-page":"3004","DOI":"10.1182\/blood-2005-02-0461","volume":"106","author":"JY Bertrand","year":"2005","unstructured":"Bertrand, J. Y. et al. Three pathways to mature macrophages in the early mouse yolk sac. Blood 106, 3004\u20133011 (2005).","journal-title":"Blood"},{"key":"2907_CR20","doi-asserted-by":"publisher","first-page":"891","DOI":"10.1242\/dev.113.3.891","volume":"113","author":"KA Lawson","year":"1991","unstructured":"Lawson, K. A., Meneses, J. J. & Pedersen, R. A. Clonal analysis of epiblast fate during germ layer formation in the mouse embryo. Development 113, 891\u2013911 (1991).","journal-title":"Development"},{"key":"2907_CR21","doi-asserted-by":"publisher","first-page":"3473","DOI":"10.1242\/dev.02499","volume":"133","author":"C Park","year":"2006","unstructured":"Park, C. et al. Bone morphogenetic protein receptor 1A signaling is dispensable for hematopoietic development but essential for vessel and atrioventricular endocardial cushion formation. Development 133, 3473\u20133484 (2006).","journal-title":"Development"},{"key":"2907_CR22","doi-asserted-by":"publisher","first-page":"16160","DOI":"10.1073\/pnas.1007725107","volume":"107","author":"HT Tran","year":"2010","unstructured":"Tran, H. T., Sekkali, B., van Imschoot, G., Janssens, S. & Vleminckx, K. Wnt\/beta-catenin signaling is involved in the induction and maintenance of primitive hematopoiesis in the vertebrate embryo. Proc. Natl. Acad. Sci. USA. 107, 16160\u201316165 (2010).","journal-title":"Proc. Natl. Acad. Sci. USA."},{"key":"2907_CR23","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1242\/dev.118.2.489","volume":"118","author":"TP Yamaguchi","year":"1993","unstructured":"Yamaguchi, T. P., Dumont, D. J., Conlon, R. A., Breitman, M. L. & Rossant, J. flk-1, an flt-related receptor tyrosine kinase is an early marker for endothelial cell precursors. Development 118, 489\u2013498 (1993).","journal-title":"Development"},{"key":"2907_CR24","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1002\/aja.1002030109","volume":"203","author":"DJ Dumont","year":"1995","unstructured":"Dumont, D. J. et al. Vascularization of the mouse embryo: a study of flk-1, tek, tie, and vascular endothelial growth factor expression during development. Dev. Dyn. 203, 80\u201392 (1995).","journal-title":"Dev. Dyn."},{"key":"2907_CR25","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1387\/ijdb.041957mt","volume":"49","author":"M Tavian","year":"2005","unstructured":"Tavian, M. & P\u00e9ault, B. Embryonic development of the human hematopoietic system. Int. J. Dev. Biol. 49, 243\u2013250 (2005).","journal-title":"Int. J. Dev. Biol."},{"key":"2907_CR26","doi-asserted-by":"publisher","first-page":"1283","DOI":"10.1084\/jem.174.5.1283","volume":"174","author":"B P\u00e9ault","year":"1991","unstructured":"P\u00e9ault, B., Weissman, I. L., Baum, C., McCune, J. M. & Tsukamoto, A. Lymphoid reconstitution of the human fetal thymus in SCID mice with CD34+ precursor cells. J. Exp. Med. 174, 1283\u20131286 (1991).","journal-title":"J. Exp. Med."},{"key":"2907_CR27","doi-asserted-by":"publisher","first-page":"725","DOI":"10.1242\/dev.125.4.725","volume":"125","author":"K Choi","year":"1998","unstructured":"Choi, K., Kennedy, M., Kazarov, A., Papadimitriou, J. C. & Keller, G. A common precursor for hematopoietic and endothelial cells. Development 125, 725\u2013732 (1998).","journal-title":"Development"},{"key":"2907_CR28","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1111\/j.1365-2141.1970.tb01443.x","volume":"18","author":"MA Moore","year":"1970","unstructured":"Moore, M. A. & Metcalf, D. Ontogeny of the haemopoietic system: yolk sac origin of in vivo and in vitro colony forming cells in the developing mouse embryo. Br. J. Haematol. 18, 279\u2013296 (1970).","journal-title":"Br. J. Haematol."},{"key":"2907_CR29","doi-asserted-by":"publisher","first-page":"5073","DOI":"10.1242\/dev.126.22.5073","volume":"126","author":"J Palis","year":"1999","unstructured":"Palis, J., Robertson, S., Kennedy, M., Wall, C. & Keller, G. Development of erythroid and myeloid progenitors in the yolk sac and embryo proper of the mouse. Development 126, 5073\u20135084 (1999).","journal-title":"Development"},{"key":"2907_CR30","doi-asserted-by":"publisher","first-page":"3851","DOI":"10.1073\/pnas.83.11.3851","volume":"83","author":"PM Wong","year":"1986","unstructured":"Wong, P. M., Chung, S. W., Chui, D. H. & Eaves, C. J. Properties of the earliest clonogenic hemopoietic precursors to appear in the developing murine yolk sac. Proc. Natl. Acad. Sci. USA. 83, 3851\u20133854 (1986).","journal-title":"Proc. Natl. Acad. Sci. USA."},{"key":"2907_CR31","doi-asserted-by":"publisher","first-page":"2636","DOI":"10.1182\/blood-2007-11-124685","volume":"111","author":"J Tober","year":"2008","unstructured":"Tober, J., McGrath, K. E. & Palis, J. Primitive erythropoiesis and megakaryopoiesis in the yolk sac are independent of c-myb. Blood 111, 2636\u20132639 (2008).","journal-title":"Blood"},{"key":"2907_CR32","doi-asserted-by":"publisher","first-page":"1669","DOI":"10.1182\/blood-2002-08-2531","volume":"101","author":"KE McGrath","year":"2003","unstructured":"McGrath, K. E., Koniski, A. D., Malik, J. & Palis, J. Circulation is established in a stepwise pattern in the mammalian embryo. Blood 101, 1669\u20131676 (2003).","journal-title":"Blood"},{"key":"2907_CR33","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1161\/01.RES.0000056532.18710.C0","volume":"92","author":"RP Ji","year":"2003","unstructured":"Ji, R. P. et al. Onset of cardiac function during early mouse embryogenesis coincides with entry of primitive erythroblasts into the embryo proper. Circ. Res. 92, 133\u2013135 (2003).","journal-title":"Circ. Res."},{"key":"2907_CR34","doi-asserted-by":"publisher","first-page":"3735","DOI":"10.1242\/dev.126.17.3735","volume":"126","author":"P Herbomel","year":"1999","unstructured":"Herbomel, P., Thisse, B. & Thisse, C. Ontogeny and behaviour of early macrophages in the zebrafish embryo. Development 126, 3735\u20133745 (1999).","journal-title":"Development"},{"key":"2907_CR35","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1093\/intimm\/dxy044","volume":"30","author":"E Mass","year":"2018","unstructured":"Mass, E. Delineating the origins, developmental programs and homeostatic functions of tissue-resident macrophages. Int. Immunol. 30, 493\u2013501 (2018).","journal-title":"Int. Immunol."},{"key":"2907_CR36","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1038\/313235a0","volume":"313","author":"C Peschle","year":"1985","unstructured":"Peschle, C. et al. Haemoglobin switching in human embryos: asynchrony of zeta-alpha and epsilon-gamma-globin switches in primitive and definite erythropoietic lineage. Nature 313, 235\u2013238 (1985).","journal-title":"Nature"},{"key":"2907_CR37","doi-asserted-by":"publisher","first-page":"4075","DOI":"10.1182\/blood-2007-05-091637","volume":"111","author":"T Yokomizo","year":"2008","unstructured":"Yokomizo, T. et al. Runx1 is involved in primitive erythropoiesis in the mouse. Blood 111, 4075\u20134080 (2008).","journal-title":"Blood"},{"key":"2907_CR38","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1007\/978-981-10-3233-2_4","volume":"962","author":"AD Yzaguirre","year":"2017","unstructured":"Yzaguirre, A. D., de Bruijn, M. F. T. R. & Speck, N. A. The role of Runx1 in embryonic blood cell formation. Adv. Exp. Med. Biol. 962, 47\u201364 (2017).","journal-title":"Adv. Exp. Med. Biol."},{"key":"2907_CR39","doi-asserted-by":"publisher","first-page":"1892","DOI":"10.1016\/j.celrep.2015.05.036","volume":"11","author":"KE McGrath","year":"2015","unstructured":"McGrath, K. E. et al. Distinct sources of hematopoietic progenitors emerge before HSCs and provide functional blood cells in the mammalian embryo. Cell Rep. 11, 1892\u20131904 (2015).","journal-title":"Cell Rep."},{"key":"2907_CR40","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1038\/nature13989","volume":"518","author":"E Gomez Perdiguero","year":"2015","unstructured":"Gomez Perdiguero, E. et al. Tissue-resident macrophages originate from yolk-sac-derived erythro-myeloid progenitors. Nature 518, 547\u2013551 (2015).","journal-title":"Nature"},{"key":"2907_CR41","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1016\/1074-7613(94)90081-7","volume":"1","author":"AM M\u00fcller","year":"1994","unstructured":"M\u00fcller, A. M., Medvinsky, A., Strouboulis, J., Grosveld, F. & Dzierzak, E. Development of hematopoietic stem cell activity in the mouse embryo. Immunity 1, 291\u2013301 (1994).","journal-title":"Immunity"},{"key":"2907_CR42","doi-asserted-by":"publisher","first-page":"665","DOI":"10.1016\/j.immuni.2015.03.011","volume":"42","author":"G Hoeffel","year":"2015","unstructured":"Hoeffel, G. et al. C-Myb(+) erythro-myeloid progenitor-derived fetal monocytes give rise to adult tissue-resident macrophages. Immunity 42, 665\u2013678 (2015).","journal-title":"Immunity"},{"key":"2907_CR43","doi-asserted-by":"publisher","first-page":"4393","DOI":"10.1242\/dev.00632","volume":"130","author":"MJ Ferkowicz","year":"2003","unstructured":"Ferkowicz, M. J. et al. CD41 expression defines the onset of primitive and definitive hematopoiesis in the murine embryo. Development 130, 4393\u20134403 (2003).","journal-title":"Development"},{"key":"2907_CR44","doi-asserted-by":"publisher","first-page":"508","DOI":"10.1182\/blood-2002-06-1699","volume":"101","author":"HKA Mikkola","year":"2003","unstructured":"Mikkola, H. K. A., Fujiwara, Y., Schlaeger, T. M., Traver, D. & Orkin, S. H. Expression of CD41 marks the initiation of definitive hematopoiesis in the mouse embryo. Blood 101, 508\u2013516 (2003).","journal-title":"Blood"},{"key":"2907_CR45","doi-asserted-by":"publisher","first-page":"5088","DOI":"10.1182\/blood-2011-01-329516","volume":"117","author":"C Robin","year":"2011","unstructured":"Robin, C., Ottersbach, K., Boisset, J.-C., Oziemlak, A. & Dzierzak, E. CD41 is developmentally regulated and differentially expressed on mouse hematopoietic stem cells. Blood 117, 5088\u20135091 (2011).","journal-title":"Blood"},{"key":"2907_CR46","doi-asserted-by":"publisher","first-page":"4891","DOI":"10.1242\/dev.129.21.4891","volume":"129","author":"P Kumaravelu","year":"2002","unstructured":"Kumaravelu, P. et al. Quantitative developmental anatomy of definitive haematopoietic stem cells\/long-term repopulating units (HSC\/RUs): role of the aorta-gonad-mesonephros (AGM) region and the yolk sac in colonisation of the mouse embryonic liver. Development 129, 4891\u20134899 (2002).","journal-title":"Development"},{"key":"2907_CR47","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1038\/nature08764","volume":"464","author":"J-C Boisset","year":"2010","unstructured":"Boisset, J.-C. et al. In vivo imaging of haematopoietic cells emerging from the mouse aortic endothelium. Nature 464, 116\u2013120 (2010).","journal-title":"Nature"},{"key":"2907_CR48","doi-asserted-by":"publisher","first-page":"833","DOI":"10.1016\/S0960-9822(99)80368-6","volume":"9","author":"YS Mukouyama","year":"1999","unstructured":"Mukouyama, Y. S. et al. Hematopoietic cells in cultures of the murine embryonic aorta-gonad-mesonephros region are induced by c-Myb. Curr. Biol. 9, 833\u2013836 (1999).","journal-title":"Curr. Biol."},{"key":"2907_CR49","doi-asserted-by":"publisher","first-page":"3335","DOI":"10.1038\/sj.onc.1203660","volume":"19","author":"R Sumner","year":"2000","unstructured":"Sumner, R., Crawford, A., Mucenski, M. & Frampton, J. Initiation of adult myelopoiesis can occur in the absence of c-Myb whereas subsequent development is strictly dependent on the transcription factor. Oncogene 19, 3335\u20133342 (2000).","journal-title":"Oncogene"},{"key":"2907_CR50","doi-asserted-by":"publisher","first-page":"534","DOI":"10.1038\/s41586-022-04571-x","volume":"604","author":"V Calvanese","year":"2022","unstructured":"Calvanese, V. et al. Mapping human haematopoietic stem cells from haemogenic endothelium to birth. Nature 604, 534\u2013540 (2022).","journal-title":"Nature"},{"key":"2907_CR51","doi-asserted-by":"publisher","first-page":"595","DOI":"10.1038\/ncb3354","volume":"18","author":"DR Dou","year":"2016","unstructured":"Dou, D. R. et al. Medial HOXA genes demarcate haematopoietic stem cell fate during human development. Nat. Cell Biol. 18, 595\u2013606 (2016).","journal-title":"Nat. Cell Biol."},{"key":"2907_CR52","doi-asserted-by":"publisher","first-page":"1342","DOI":"10.1016\/j.immuni.2019.05.017","volume":"50","author":"L Bennett","year":"2019","unstructured":"Bennett, L., Mumau, M. & Speck, N. A. Macrophages fertilize the soil to promote hematopoietic cell growth. Immunity 50, 1342\u20131344 (2019).","journal-title":"Immunity"},{"key":"2907_CR53","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1146\/annurev-cellbio-020520-114601","volume":"36","author":"JN Pucella","year":"2020","unstructured":"Pucella, J. N., Upadhaya, S. & Reizis, B. The source and dynamics of adult hematopoiesis: insights from lineage tracing. Annu. Rev. Cell Dev. Biol. 36, 529\u2013550 (2020).","journal-title":"Annu. Rev. Cell Dev. Biol."},{"key":"2907_CR54","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1038\/nri.2017.53","volume":"17","author":"GM Crane","year":"2017","unstructured":"Crane, G. M., Jeffery, E. & Morrison, S. J. Adult haematopoietic stem cell niches. Nat. Rev. Immunol. 17, 573\u2013590 (2017).","journal-title":"Nat. Rev. Immunol."},{"key":"2907_CR55","doi-asserted-by":"publisher","first-page":"418","DOI":"10.1038\/nature25022","volume":"553","author":"E Laurenti","year":"2018","unstructured":"Laurenti, E. & G\u00f6ttgens, B. From haematopoietic stem cells to complex differentiation landscapes. Nature 553, 418\u2013426 (2018).","journal-title":"Nature"},{"key":"2907_CR56","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1146\/annurev.ph.58.030196.001311","volume":"58","author":"KS Zaret","year":"1996","unstructured":"Zaret, K. S. Molecular genetics of early liver development. Annu. Rev. Physiol. 58, 231\u2013251 (1996).","journal-title":"Annu. Rev. Physiol."},{"key":"2907_CR57","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-020-17575-w","volume":"11","author":"C Ross","year":"2020","unstructured":"Ross, C. & Boroviak, T. E. Origin and function of the yolk sac in primate embryogenesis. Nat. Commun. 11, 3760 (2020).","journal-title":"Nat. Commun."},{"key":"2907_CR58","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1002\/aja.1001520106","volume":"152","author":"WP Luckett","year":"1978","unstructured":"Luckett, W. P. Origin and differentiation of the yolk sac and extraembryonic mesoderm in presomite human and rhesus monkey embryos. Am. J. Anat. 152, 59\u201397 (1978).","journal-title":"Am. J. Anat."},{"key":"2907_CR59","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1007\/BF02889187","volume":"14","author":"T Fukuda","year":"1973","unstructured":"Fukuda, T. Fetal hemopoiesis. I. Electron microscopic studies on human yolk sac hemopoiesis. Virchows Arch. B Cell Pathol. 14, 197\u2013213 (1973).","journal-title":"Virchows Arch. B Cell Pathol."},{"key":"2907_CR60","first-page":"23","volume":"9","author":"M Dommergues","year":"1992","unstructured":"Dommergues, M., Aub\u00e9ny, E., Dumez, Y., Durandy, A. & Coulombel, L. Hematopoiesis in the human yolk sac: quantitation of erythroid and granulopoietic progenitors between 3.5 and 8 weeks of development. Bone Marrow Transpl. 9, 23\u201327 (1992).","journal-title":"Bone Marrow Transpl."},{"key":"2907_CR61","doi-asserted-by":"publisher","first-page":"4474","DOI":"10.1182\/blood.V86.12.4474.bloodjournal86124474","volume":"86","author":"A Huyhn","year":"1995","unstructured":"Huyhn, A. et al. Characterization of hematopoietic progenitors from human yolk sacs and embryos. Blood 86, 4474\u20134485 (1995).","journal-title":"Blood"},{"key":"2907_CR62","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1172\/JCI112572","volume":"78","author":"G Migliaccio","year":"1986","unstructured":"Migliaccio, G. et al. Human embryonic hemopoiesis. Kinetics of progenitors and precursors underlying the yolk sac-liver transition. J. Clin. Investig. 78, 51\u201360 (1986).","journal-title":"J. Clin. Investig."},{"key":"2907_CR63","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1016\/S1074-7613(01)00193-5","volume":"15","author":"M Tavian","year":"2001","unstructured":"Tavian, M., Robin, C., Coulombel, L. & P\u00e9ault, B. The human embryo, but not its yolk sac, generates lympho-myeloid stem cells: mapping multipotent hematopoietic cell fate in intraembryonic mesoderm. Immunity 15, 487\u2013495 (2001).","journal-title":"Immunity"},{"key":"2907_CR64","doi-asserted-by":"publisher","first-page":"793","DOI":"10.1242\/dev.126.4.793","volume":"126","author":"M Tavian","year":"1999","unstructured":"Tavian, M., Hallais, M. F. & P\u00e9ault, B. Emergence of intraembryonic hematopoietic precursors in the pre-liver human embryo. Development 126, 793\u2013803 (1999).","journal-title":"Development"},{"key":"2907_CR65","doi-asserted-by":"publisher","first-page":"2417","DOI":"10.1084\/jem.20111688","volume":"208","author":"A Ivanovs","year":"2011","unstructured":"Ivanovs, A. et al. Highly potent human hematopoietic stem cells first emerge in the intraembryonic aorta-gonad-mesonephros region. J. Exp. Med. 208, 2417\u20132427 (2011).","journal-title":"J. Exp. Med."},{"key":"2907_CR66","doi-asserted-by":"publisher","first-page":"3763","DOI":"10.1182\/blood.V96.12.3763","volume":"96","author":"I Blazsek","year":"2000","unstructured":"Blazsek, I., Chagraoui, J. & P\u00e9ault, B. Ontogenic emergence of the hematon, a morphogenetic stromal unit that supports multipotential hematopoietic progenitors in mouse bone marrow. Blood 96, 3763\u20133771 (2000).","journal-title":"Blood"},{"key":"2907_CR67","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1038\/s41586-021-04158-y","volume":"600","author":"RCV Tyser","year":"2021","unstructured":"Tyser, R. C. V. et al. Single-cell transcriptomic characterization of a gastrulating human embryo. Nature 600, 285\u2013289 (2021).","journal-title":"Nature"},{"key":"2907_CR68","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1038\/s41586-020-2316-7","volume":"582","author":"Z Bian","year":"2020","unstructured":"Bian, Z. et al. Deciphering human macrophage development at single-cell resolution. Nature 582, 571\u2013576 (2020).","journal-title":"Nature"},{"key":"2907_CR69","doi-asserted-by":"publisher","first-page":"4454","DOI":"10.1016\/j.cell.2023.08.019","volume":"186","author":"Z Wang","year":"2023","unstructured":"Wang, Z. et al. An immune cell atlas reveals the dynamics of human macrophage specification during prenatal development. Cell 186, 4454\u20134471.e19 (2023).","journal-title":"Cell"},{"key":"2907_CR70","doi-asserted-by":"publisher","DOI":"10.1126\/science.add7564","volume":"381","author":"I Goh","year":"2023","unstructured":"Goh, I. et al. Yolk sac cell atlas reveals multiorgan functions during human early development. Science 381, eadd7564 (2023).","journal-title":"Science"},{"key":"2907_CR71","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1038\/s41586-019-1652-y","volume":"574","author":"D-M Popescu","year":"2019","unstructured":"Popescu, D.-M. et al. Decoding human fetal liver haematopoiesis. Nature 574, 365\u2013371 (2019).","journal-title":"Nature"},{"key":"2907_CR72","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-022-28616-x","volume":"13","author":"K Vanuytsel","year":"2022","unstructured":"Vanuytsel, K. et al. Multi-modal profiling of human fetal liver hematopoietic stem cells reveals the molecular signature of engraftment. Nat. Commun. 13, 1103 (2022).","journal-title":"Nat. Commun."},{"key":"2907_CR73","doi-asserted-by":"publisher","first-page":"472","DOI":"10.1016\/j.stem.2020.11.015","volume":"28","author":"AM Ranzoni","year":"2021","unstructured":"Ranzoni, A. M. et al. Integrative single-cell RNA-Seq and ATAC-Seq analysis of human developmental hematopoiesis. Cell Stem Cell 28, 472\u2013487.e7 (2021).","journal-title":"Cell Stem Cell"},{"key":"2907_CR74","doi-asserted-by":"publisher","DOI":"10.1126\/science.abo0510","volume":"376","author":"C Suo","year":"2022","unstructured":"Suo, C. et al. Mapping the developing human immune system across organs. Science 376, eabo0510 (2022).","journal-title":"Science"},{"key":"2907_CR75","doi-asserted-by":"publisher","first-page":"663","DOI":"10.1016\/j.cell.2006.07.024","volume":"126","author":"K Takahashi","year":"2006","unstructured":"Takahashi, K. & Yamanaka, S. Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell 126, 663\u2013676 (2006).","journal-title":"Cell"},{"key":"2907_CR76","doi-asserted-by":"publisher","first-page":"861","DOI":"10.1016\/j.cell.2007.11.019","volume":"131","author":"K Takahashi","year":"2007","unstructured":"Takahashi, K. et al. Induction of pluripotent stem cells from adult human fibroblasts by defined factors. Cell 131, 861\u2013872 (2007).","journal-title":"Cell"},{"key":"2907_CR77","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1038\/mt.2011.41","volume":"19","author":"KH Narsinh","year":"2011","unstructured":"Narsinh, K. H., Plews, J. & Wu, J. C. Comparison of human induced pluripotent and embryonic stem cells: fraternal or identical twins? Mol. Ther. 19, 635\u2013638 (2011).","journal-title":"Mol. Ther."},{"key":"2907_CR78","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1038\/cr.2012.175","volume":"23","author":"G Liang","year":"2013","unstructured":"Liang, G. & Zhang, Y. Embryonic stem cell and induced pluripotent stem cell: an epigenetic perspective. Cell Res. 23, 49\u201369 (2013).","journal-title":"Cell Res."},{"key":"2907_CR79","doi-asserted-by":"publisher","first-page":"e30","DOI":"10.1161\/CIRCRESAHA.108.192237","volume":"104","author":"J Zhang","year":"2009","unstructured":"Zhang, J. et al. Functional cardiomyocytes derived from human induced pluripotent stem cells. Circ. Res. 104, e30\u2013e41 (2009).","journal-title":"Circ. Res."},{"key":"2907_CR80","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1038\/cr.2009.28","volume":"19","author":"D Zhang","year":"2009","unstructured":"Zhang, D. et al. Highly efficient differentiation of human ES cells and iPS cells into mature pancreatic insulin-producing cells. Cell Res. 19, 429\u2013438 (2009).","journal-title":"Cell Res."},{"key":"2907_CR81","doi-asserted-by":"publisher","first-page":"31601","DOI":"10.1074\/jbc.M806597200","volume":"283","author":"K Tateishi","year":"2008","unstructured":"Tateishi, K. et al. Generation of insulin-secreting islet-like clusters from human skin fibroblasts. J. Biol. Chem. 283, 31601\u201331607 (2008).","journal-title":"J. Biol. Chem."},{"key":"2907_CR82","doi-asserted-by":"publisher","first-page":"1893","DOI":"10.1002\/stem.499","volume":"28","author":"A Swistowski","year":"2010","unstructured":"Swistowski, A. et al. Efficient generation of functional dopaminergic neurons from human induced pluripotent stem cells under defined conditions. Stem Cells 28, 1893\u20131904 (2010).","journal-title":"Stem Cells"},{"key":"2907_CR83","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-018-07570-7","volume":"9","author":"M Ackermann","year":"2018","unstructured":"Ackermann, M. et al. Bioreactor-based mass production of human iPSC-derived macrophages enables immunotherapies against bacterial airway infections. Nat. Commun. 9, 5088 (2018).","journal-title":"Nat. Commun."},{"key":"2907_CR84","doi-asserted-by":"publisher","first-page":"1394","DOI":"10.5966\/sctm.2015-0371","volume":"5","author":"EN Olivier","year":"2016","unstructured":"Olivier, E. N. et al. High-efficiency serum-free feeder-free erythroid differentiation of human pluripotent stem cells using small molecules. Stem Cells Transl. Med. 5, 1394\u20131405 (2016).","journal-title":"Stem Cells Transl. Med."},{"key":"2907_CR85","doi-asserted-by":"publisher","first-page":"S50","DOI":"10.1038\/cr.2008.140","volume":"18","author":"Y Wang","year":"2008","unstructured":"Wang, Y., Xu, H., Li, J., Wan, H. & Jin, S. The expression of BMP4 during the hematopoiesis of human yolk sac. Cell Res. 18, S50\u2013S50 (2008).","journal-title":"Cell Res."},{"key":"2907_CR86","doi-asserted-by":"publisher","first-page":"4393","DOI":"10.1182\/blood-2009-02-206433","volume":"114","author":"DC Goldman","year":"2009","unstructured":"Goldman, D. C. et al. BMP4 regulates the hematopoietic stem cell niche. Blood 114, 4393\u20134401 (2009).","journal-title":"Blood"},{"key":"2907_CR87","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1161\/ATVBAHA.109.194233","volume":"30","author":"MB Nourse","year":"2010","unstructured":"Nourse, M. B. et al. VEGF induces differentiation of functional endothelium from human embryonic stem cells: implications for tissue engineering. Arterioscler. Thromb. Vasc. Biol. 30, 80\u201389 (2010).","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"2907_CR88","doi-asserted-by":"publisher","first-page":"1354","DOI":"10.3324\/haematol.2019.228064","volume":"106","author":"M Ackermann","year":"2021","unstructured":"Ackermann, M. et al. A 3D iPSC-differentiation model identifies interleukin-3 as a regulator of early human hematopoietic specification. Haematologica 106, 1354\u20131367 (2021).","journal-title":"Haematologica"},{"key":"2907_CR89","doi-asserted-by":"publisher","first-page":"e20211924","DOI":"10.1084\/jem.20211924","volume":"219","author":"MH Atkins","year":"2022","unstructured":"Atkins, M. H. et al. Modeling human yolk sac hematopoiesis with pluripotent stem cells. J. Exp. Med. 219, e20211924 (2022).","journal-title":"J. Exp. Med."},{"key":"2907_CR90","doi-asserted-by":"publisher","first-page":"685","DOI":"10.1093\/stmcls\/sxad040","volume":"41","author":"Y Li","year":"2023","unstructured":"Li, Y., Ding, J., Araki, D., Zou, J. & Larochelle, A. Modulation of WNT, activin\/Nodal, and MAPK signaling pathways increases arterial hemogenic endothelium and hematopoietic stem\/progenitor cell formation during human iPSC differentiation. Stem Cells 41, 685\u2013697 (2023).","journal-title":"Stem Cells"},{"key":"2907_CR91","doi-asserted-by":"publisher","first-page":"1345","DOI":"10.1182\/blood.V90.4.1345","volume":"90","author":"VC Broudy","year":"1997","unstructured":"Broudy, V. C. Stem cell factor and hematopoiesis. Blood 90, 1345\u20131364 (1997).","journal-title":"Blood"},{"key":"2907_CR92","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1038\/s41586-023-06473-y","volume":"621","author":"C Li","year":"2023","unstructured":"Li, C. et al. Single-cell brain organoid screening identifies developmental defects in autism. Nature 621, 373\u2013380 (2023).","journal-title":"Nature"},{"key":"2907_CR93","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-023-39740-7","volume":"14","author":"M Lass\u00e9","year":"2023","unstructured":"Lass\u00e9, M. et al. An integrated organoid omics map extends modeling potential of kidney disease. Nat. Commun. 14, 4903 (2023).","journal-title":"Nat. Commun."},{"key":"2907_CR94","doi-asserted-by":"publisher","first-page":"771","DOI":"10.1016\/j.devcel.2020.11.010","volume":"55","author":"R Elmentaite","year":"2020","unstructured":"Elmentaite, R. et al. Single-cell sequencing of developing human gut reveals transcriptional links to childhood Crohn\u2019s Disease. Dev. Cell 55, 771\u2013783.e5 (2020).","journal-title":"Dev. Cell"},{"key":"2907_CR95","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1038\/s41575-025-01050-2","volume":"22","author":"MC Ortu\u00f1o-Costela","year":"2025","unstructured":"Ortu\u00f1o-Costela, M. C., Pinzani, M. & Vallier, L. Cell therapy for liver disorders: past, present and future. Nat. Rev. Gastroenterol. Hepatol. 22, 329\u2013342 (2025).","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"2907_CR96","doi-asserted-by":"publisher","first-page":"100460","DOI":"10.1016\/j.crmeth.2023.100460","volume":"3","author":"N Tamaoki","year":"2023","unstructured":"Tamaoki, N. et al. Self-organized yolk sac-like organoids allow for scalable generation of multipotent hematopoietic progenitor cells from induced pluripotent stem cells. Cell Rep. Methods 3, 100460 (2023).","journal-title":"Cell Rep. Methods"},{"key":"2907_CR97","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1016\/j.immuni.2017.06.017","volume":"47","author":"K Takata","year":"2017","unstructured":"Takata, K. et al. Induced-pluripotent-stem-cell-derived primitive macrophages provide a platform for modeling tissue-resident macrophage differentiation and function. Immunity 47, 183\u2013198.e6 (2017).","journal-title":"Immunity"},{"key":"2907_CR98","doi-asserted-by":"publisher","first-page":"334","DOI":"10.1016\/j.stemcr.2016.12.020","volume":"8","author":"J Buchrieser","year":"2017","unstructured":"Buchrieser, J., James, W. & Moore, M. D. Human induced pluripotent stem cell-derived macrophages share ontogeny with MYB-independent tissue-resident macrophages. Stem Cell Rep. 8, 334\u2013345 (2017).","journal-title":"Stem Cell Rep."},{"key":"2907_CR99","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1002\/stem.2739","volume":"36","author":"MG Angelos","year":"2018","unstructured":"Angelos, M. G., Abrahante, J. E., Blum, R. H. & Kaufman, D. S. Single cell resolution of human hematoendothelial cells defines transcriptional signatures of hemogenic endothelium. Stem Cells 36, 206\u2013217 (2018).","journal-title":"Stem Cells"},{"key":"2907_CR100","doi-asserted-by":"publisher","first-page":"887","DOI":"10.1038\/nature07619","volume":"457","author":"MJ Chen","year":"2009","unstructured":"Chen, M. J., Yokomizo, T., Zeigler, B. M., Dzierzak, E. & Speck, N. A. Runx1 is required for the endothelial to haematopoietic cell transition but not thereafter. Nature 457, 887\u2013891 (2009).","journal-title":"Nature"},{"key":"2907_CR101","doi-asserted-by":"publisher","first-page":"270","DOI":"10.3389\/fimmu.2018.00270","volume":"9","author":"C Diskin","year":"2018","unstructured":"Diskin, C. & P\u00e5lsson-McDermott, E. M. Metabolic modulation in macrophage effector function. Front. Immunol. 9, 270 (2018).","journal-title":"Front. Immunol."},{"key":"2907_CR102","doi-asserted-by":"publisher","first-page":"289","DOI":"10.3389\/fimmu.2017.00289","volume":"8","author":"X Geeraerts","year":"2017","unstructured":"Geeraerts, X., Bolli, E., Fendt, S.-M. & van Ginderachter, J. A. Macrophage metabolism as therapeutic target for cancer, atherosclerosis, and obesity. Front. Immunol. 8, 289 (2017).","journal-title":"Front. Immunol."},{"key":"2907_CR103","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1016\/j.immuni.2014.06.008","volume":"41","author":"PJ Murray","year":"2014","unstructured":"Murray, P. J. et al. Macrophage activation and polarization: nomenclature and experimental guidelines. Immunity 41, 14\u201320 (2014).","journal-title":"Immunity"},{"key":"2907_CR104","doi-asserted-by":"publisher","first-page":"954","DOI":"10.1016\/j.it.2023.10.006","volume":"44","author":"G Katkar","year":"2023","unstructured":"Katkar, G. & Ghosh, P. Macrophage states: there\u2019s a method in the madness. Trends Immunol. 44, 954\u2013964 (2023).","journal-title":"Trends Immunol."},{"key":"2907_CR105","doi-asserted-by":"publisher","first-page":"1883","DOI":"10.1016\/j.immuni.2021.07.007","volume":"54","author":"K Mulder","year":"2021","unstructured":"Mulder, K. et al. Cross-tissue single-cell landscape of human monocytes and macrophages in health and disease. Immunity 54, 1883\u20131900.e5 (2021).","journal-title":"Immunity"},{"key":"2907_CR106","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1038\/s41392-024-01840-1","volume":"9","author":"R Chen","year":"2024","unstructured":"Chen, R. et al. Macrophages in cardiovascular diseases: molecular mechanisms and therapeutic targets. Signal Transduct. Target. Ther. 9, 130 (2024).","journal-title":"Signal Transduct. Target. Ther."},{"key":"2907_CR107","doi-asserted-by":"publisher","DOI":"10.1002\/adma.202209041","volume":"35","author":"W Chen","year":"2023","unstructured":"Chen, W. et al. A matrix-metalloproteinase-responsive hydrogel system for modulating the immune microenvironment in myocardial infarction. Adv. Mater. 35, e2209041 (2023).","journal-title":"Adv. Mater."},{"key":"2907_CR108","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1007\/s00395-017-0622-5","volume":"112","author":"M Jung","year":"2017","unstructured":"Jung, M. et al. IL-10 improves cardiac remodeling after myocardial infarction by stimulating M2 macrophage polarization and fibroblast activation. Basic Res. Cardiol. 112, 33 (2017).","journal-title":"Basic Res. Cardiol."},{"key":"2907_CR109","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1093\/cvr\/cvy200","volume":"115","author":"M Tokutome","year":"2019","unstructured":"Tokutome, M. et al. Peroxisome proliferator-activated receptor-gamma targeting nanomedicine promotes cardiac healing after acute myocardial infarction by skewing monocyte\/macrophage polarization in preclinical animal models. Cardiovasc. Res. 115, 419\u2013431 (2019).","journal-title":"Cardiovasc. Res."},{"key":"2907_CR110","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1016\/j.freeradbiomed.2017.01.035","volume":"104","author":"T-M Lee","year":"2017","unstructured":"Lee, T.-M., Chang, N.-C. & Lin, S.-Z. Dapagliflozin, a selective SGLT2 Inhibitor, attenuated cardiac fibrosis by regulating the macrophage polarization via STAT3 signaling in infarcted rat hearts. Free Radic. Biol. Med. 104, 298\u2013310 (2017).","journal-title":"Free Radic. Biol. Med."},{"key":"2907_CR111","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1007\/s00395-019-0742-1","volume":"114","author":"M-N Podaru","year":"2019","unstructured":"Podaru, M.-N. et al. Reparative macrophage transplantation for myocardial repair: a refinement of bone marrow mononuclear cell-based therapy. Basic Res. Cardiol. 114, 34 (2019).","journal-title":"Basic Res. Cardiol."},{"key":"2907_CR112","doi-asserted-by":"publisher","first-page":"307","DOI":"10.7150\/thno.63642","volume":"12","author":"Y Zhu","year":"2022","unstructured":"Zhu, Y. et al. Hypoxia-primed monocytes\/macrophages enhance postinfarction myocardial repair. Theranostics 12, 307\u2013323 (2022).","journal-title":"Theranostics"},{"key":"2907_CR113","doi-asserted-by":"publisher","DOI":"10.1002\/adhm.202303267","volume":"13","author":"H Tan","year":"2024","unstructured":"Tan, H. et al. Genetically engineered macrophages co-loaded with CD47 inhibitors synergistically reconstruct efferocytosis and improve cardiac remodeling post myocardial ischemia reperfusion injury. Adv. Healthc. Mater. 13, e2303267 (2024).","journal-title":"Adv. Healthc. Mater."},{"key":"2907_CR114","doi-asserted-by":"publisher","first-page":"1161","DOI":"10.1161\/CIRCRESAHA.124.325212","volume":"135","author":"J Wang","year":"2024","unstructured":"Wang, J. et al. CAR-macrophage therapy alleviates myocardial ischemia-reperfusion injury. Circ. Res. 135, 1161\u20131174 (2024).","journal-title":"Circ. Res."},{"key":"2907_CR115","doi-asserted-by":"publisher","first-page":"846","DOI":"10.1161\/CIRCRESAHA.125.326716","volume":"137","author":"H Du","year":"2025","unstructured":"Du, H. et al. CAR macrophages engineered in vivo for attenuating myocardial ischemia-reperfusion injury. Circ. Res. 137, 846\u2013859 (2025).","journal-title":"Circ. Res."},{"key":"2907_CR116","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1038\/nri3520","volume":"13","author":"KJ Moore","year":"2013","unstructured":"Moore, K. J., Sheedy, F. J. & Fisher, E. A. Macrophages in atherosclerosis: a dynamic balance. Nat. Rev. Immunol. 13, 709\u2013721 (2013).","journal-title":"Nat. Rev. Immunol."},{"key":"2907_CR117","doi-asserted-by":"publisher","first-page":"1799","DOI":"10.1093\/eurheartj\/ehac094","volume":"43","author":"MK Georgakis","year":"2022","unstructured":"Georgakis, M. K., Bernhagen, J., Heitman, L. H., Weber, C. & Dichgans, M. Targeting the CCL2-CCR2 axis for atheroprotection. Eur. Heart J. 43, 1799\u20131808 (2022).","journal-title":"Eur. Heart J."},{"key":"2907_CR118","doi-asserted-by":"publisher","first-page":"2700","DOI":"10.1161\/01.CIR.0000038140.80105.AD","volume":"106","author":"S Inoue","year":"2002","unstructured":"Inoue, S. et al. Anti-monocyte chemoattractant protein-1 gene therapy limits progression and destabilization of established atherosclerosis in apolipoprotein E-knockout mice. Circulation 106, 2700\u20132706 (2002).","journal-title":"Circulation"},{"key":"2907_CR119","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.125.041983","volume":"15","author":"M Shoaran","year":"2026","unstructured":"Shoaran, M. et al. Pharmacological and genetic targeting of inflammatory chemokine receptors CCR1, CCR2, and CCR5 in atherosclerosis: a systematic review and meta-analysis of preclinical studies. J. Am. Heart Assoc. 15, e041983 (2026).","journal-title":"J. Am. Heart Assoc."},{"key":"2907_CR120","doi-asserted-by":"publisher","first-page":"530","DOI":"10.1093\/cvr\/cvq235","volume":"88","author":"PI M\u00e4kinen","year":"2010","unstructured":"M\u00e4kinen, P. I. et al. Silencing of either SR-A or CD36 reduces atherosclerosis in hyperlipidaemic mice and reveals reciprocal upregulation of these receptors. Cardiovasc. Res. 88, 530\u2013538 (2010).","journal-title":"Cardiovasc. Res."},{"key":"2907_CR121","doi-asserted-by":"publisher","first-page":"2921","DOI":"10.1172\/JCI57275","volume":"121","author":"KJ Rayner","year":"2011","unstructured":"Rayner, K. J. et al. Antagonism of miR-33 in mice promotes reverse cholesterol transport and regression of atherosclerosis. J. Clin. Invest. 121, 2921\u20132931 (2011).","journal-title":"J. Clin. Invest."},{"key":"2907_CR122","doi-asserted-by":"publisher","first-page":"1361","DOI":"10.1016\/j.ajpath.2015.12.023","volume":"186","author":"K Gabunia","year":"2016","unstructured":"Gabunia, K. et al. IL-19 halts progression of atherosclerotic plaque, polarizes, and increases cholesterol uptake and efflux in macrophages. Am. J. Pathol. 186, 1361\u20131374 (2016).","journal-title":"Am. J. Pathol."},{"key":"2907_CR123","doi-asserted-by":"publisher","first-page":"2315034","DOI":"10.1002\/adfm.202315034","volume":"34","author":"Y Yao","year":"2024","unstructured":"Yao, Y. et al. A Zombie Macrophage-Based \u201cTrojan horse\u201d Enhances the Effect of Efferocytosis Through Immune Regulation for Atherosclerosis Treatment. Adv. Funct. Mater. 34, 2315034 (2024).","journal-title":"Adv. Funct. Mater."},{"key":"2907_CR124","doi-asserted-by":"publisher","DOI":"10.1186\/s40364-024-00624-7","volume":"12","author":"H Ma","year":"2024","unstructured":"Ma, H., Zhu, M., Chen, M., Li, X. & Feng, X. The role of macrophage plasticity in neurodegenerative diseases. Biomark. Res. 12, 81 (2024).","journal-title":"Biomark. Res."},{"key":"2907_CR125","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1016\/j.bbi.2021.03.013","volume":"95","author":"L Xu","year":"2021","unstructured":"Xu, L. et al. Inhibition of Smad3 in macrophages promotes A\u03b2 efflux from the brain and thereby ameliorates Alzheimer\u2019s pathology. Brain Behav. Immun. 95, 154\u2013167 (2021).","journal-title":"Brain Behav. Immun."},{"key":"2907_CR126","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1186\/s13195-025-01891-8","volume":"17","author":"H Etani","year":"2025","unstructured":"Etani, H. et al. Selective agonism of GPR34 stimulates microglial uptake and clearance of amyloid \u03b2 fibrils. Alzheimers Res. Ther. 17, 248 (2025).","journal-title":"Alzheimers Res. Ther."},{"key":"2907_CR127","doi-asserted-by":"publisher","DOI":"10.1186\/s12974-025-03558-5","volume":"22","author":"L Zhang","year":"2025","unstructured":"Zhang, L., Chen, K., Zeng, R., Bu, G. & Chen, X.-F. Soluble CSF1R promotes microglial activation and amyloid clearance in Alzheimer\u2019s disease. J. Neuroinflammation. 22, 245 (2025).","journal-title":"J. Neuroinflammation."},{"key":"2907_CR128","doi-asserted-by":"publisher","first-page":"1977","DOI":"10.1007\/s12035-017-0467-9","volume":"55","author":"J Yin","year":"2017","unstructured":"Yin, J. et al. NLRP3 inflammasome inhibitor ameliorates amyloid pathology in a mouse model of Alzheimer\u2019s disease. Mol. Neurobiol. 55, 1977\u20131987 (2017).","journal-title":"Mol. Neurobiol."},{"key":"2907_CR129","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1016\/j.bbi.2016.12.014","volume":"61","author":"C Dempsey","year":"2017","unstructured":"Dempsey, C. et al. Inhibiting the NLRP3 inflammasome with MCC950 promotes non-phlogistic clearance of amyloid-\u03b2 and cognitive function in APP\/PS1 mice. Brain Behav. Immun. 61, 306\u2013316 (2017).","journal-title":"Brain Behav. Immun."},{"key":"2907_CR130","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1038\/s41531-022-00352-5","volume":"8","author":"J Li","year":"2022","unstructured":"Li, J. et al. Melatonin ameliorates Parkinson\u2019s disease via regulating microglia polarization in a ROR\u03b1-dependent pathway. npj Parkinsons Dis. 8, 90 (2022).","journal-title":"npj Parkinsons Dis."},{"key":"2907_CR131","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1016\/j.freeradbiomed.2022.06.241","volume":"188","author":"X Zhang","year":"2022","unstructured":"Zhang, X. et al. A novel synthetic peptide SVHRSP attenuates dopaminergic neurodegeneration by inhibiting NADPH oxidase-mediated neuroinflammation in experimental models of Parkinson\u2019s disease. Free Radic. Biol. Med. 188, 363\u2013374 (2022).","journal-title":"Free Radic. Biol. Med."},{"key":"2907_CR132","doi-asserted-by":"publisher","first-page":"114854","DOI":"10.1016\/j.ejmech.2022.114854","volume":"244","author":"S Shim","year":"2022","unstructured":"Shim, S. et al. Discovery of a NADPH oxidase inhibitor, (E)-3-cyclohexyl-5-(4-((2-hydroxyethyl)(methyl)amino)benzylidene)-1-methyl-2-thioxoimidazolidin-4-oneone, as a novel therapeutic for Parkinson\u2019s disease. Eur. J. Med. Chem. 244, 114854 (2022).","journal-title":"Eur. J. Med. Chem."},{"key":"2907_CR133","doi-asserted-by":"publisher","DOI":"10.1186\/s12974-015-0455-9","volume":"12","author":"C Kim","year":"2015","unstructured":"Kim, C. et al. Hypoestoxide reduces neuroinflammation and \u03b1-synuclein accumulation in a mouse model of Parkinson\u2019s disease. J. Neuroinflammation. 12, 236 (2015).","journal-title":"J. Neuroinflammation."},{"key":"2907_CR134","doi-asserted-by":"publisher","DOI":"10.1111\/acel.70020","volume":"24","author":"F Grunenwald","year":"2025","unstructured":"Grunenwald, F. et al. IGF2-reprogrammed macrophages ameliorate the inflammatory response and protect against the neuroinflammatory process in Parkinson\u2019s disease models. Aging Cell 24, e70020 (2025).","journal-title":"Aging Cell"},{"key":"2907_CR135","doi-asserted-by":"publisher","first-page":"324","DOI":"10.1038\/s41434-024-00451-3","volume":"31","author":"G Ge","year":"2024","unstructured":"Ge, G. et al. Long-term benefits of hematopoietic stem cell-based macrophage\/microglia delivery of GDNF to the CNS in a mouse model of Parkinson\u2019s disease. Gene Ther. 31, 324\u2013334 (2024).","journal-title":"Gene Ther."},{"key":"2907_CR136","doi-asserted-by":"publisher","first-page":"3209","DOI":"10.1016\/j.ymthe.2022.05.022","volume":"30","author":"RN Plasschaert","year":"2022","unstructured":"Plasschaert, R. N. et al. High-throughput analysis of hematopoietic stem cell engraftment after intravenous and intracerebroventricular dosing. Mol. Ther. 30, 3209\u20133225 (2022).","journal-title":"Mol. Ther."},{"key":"2907_CR137","doi-asserted-by":"publisher","first-page":"1140","DOI":"10.3389\/fimmu.2019.01140","volume":"10","author":"W-T Ma","year":"2019","unstructured":"Ma, W.-T., Gao, F., Gu, K. & Chen, D.-K. The role of monocytes and macrophages in autoimmune diseases: a comprehensive review. Front. Immunol. 10, 1140 (2019).","journal-title":"Front. Immunol."},{"key":"2907_CR138","doi-asserted-by":"publisher","first-page":"121578","DOI":"10.1016\/j.biomaterials.2022.121578","volume":"286","author":"H Kim","year":"2022","unstructured":"Kim, H. et al. Extracellular vesicle-guided in situ reprogramming of synovial macrophages for the treatment of rheumatoid arthritis. Biomaterials 286, 121578 (2022).","journal-title":"Biomaterials"},{"key":"2907_CR139","doi-asserted-by":"publisher","first-page":"8824","DOI":"10.1021\/acsami.1c23429","volume":"14","author":"H Fang","year":"2022","unstructured":"Fang, H. et al. Macrophage-targeted hydroxychloroquine nanotherapeutics for rheumatoid arthritis therapy. ACS Appl. Mater. Interfaces 14, 8824\u20138837 (2022).","journal-title":"ACS Appl. Mater. Interfaces"},{"key":"2907_CR140","doi-asserted-by":"publisher","DOI":"10.1186\/s12951-024-03085-0","volume":"23","author":"R-B Guo","year":"2025","unstructured":"Guo, R.-B. et al. Treatment of rheumatoid arthritis using dual-targeted and dual-response intelligent micelles: a \u201cthree birds with one stone\u201d strategy. J. Nanobiotechnol. 23, 71 (2025).","journal-title":"J. Nanobiotechnol."},{"key":"2907_CR141","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1186\/s13075-024-03425-3","volume":"26","author":"M Klimak","year":"2024","unstructured":"Klimak, M. et al. Engineered self-regulating macrophages for targeted anti-inflammatory drug delivery. Arthritis Res. Ther. 26, 190 (2024).","journal-title":"Arthritis Res. Ther."},{"key":"2907_CR142","doi-asserted-by":"publisher","first-page":"1741","DOI":"10.1007\/s40265-019-01192-z","volume":"79","author":"C Crotti","year":"2019","unstructured":"Crotti, C., Agape, E., Becciolini, A., Biggioggero, M. & Favalli, E. G. Targeting granulocyte-monocyte colony-stimulating factor signaling in rheumatoid arthritis: future prospects. Drugs 79, 1741\u20131755 (2019).","journal-title":"Drugs"},{"key":"2907_CR143","doi-asserted-by":"publisher","first-page":"667705","DOI":"10.3389\/fimmu.2021.667705","volume":"12","author":"M Radandish","year":"2021","unstructured":"Radandish, M., Khalilian, P. & Esmaeil, N. The role of distinct subsets of macrophages in the pathogenesis of MS and the impact of different therapeutic agents on these populations. Front. Immunol. 12, 667705 (2021).","journal-title":"Front. Immunol."},{"key":"2907_CR144","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1111\/cei.13572","volume":"204","author":"F Chu","year":"2021","unstructured":"Chu, F. et al. Adoptive transfer of immunomodulatory M2 macrophages suppresses experimental autoimmune encephalomyelitis in C57BL\/6 mice via blockading NF-\u03baB pathway. Clin. Exp. Immunol. 204, 199\u2013211 (2021).","journal-title":"Clin. Exp. Immunol."},{"key":"2907_CR145","doi-asserted-by":"publisher","first-page":"e8743","DOI":"10.15252\/emmm.201708743","volume":"10","author":"A Zabala","year":"2018","unstructured":"Zabala, A. et al. P2X4 receptor controls microglia activation and favors remyelination in autoimmune encephalitis. EMBO Mol. Med. 10, e8743 (2018).","journal-title":"EMBO Mol. Med."},{"key":"2907_CR146","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1016\/j.jconrel.2016.12.003","volume":"245","author":"E Montes-Cobos","year":"2017","unstructured":"Montes-Cobos, E. et al. Targeted delivery of glucocorticoids to macrophages in a mouse model of multiple sclerosis using inorganic-organic hybrid nanoparticles. J. Control. Release 245, 157\u2013169 (2017).","journal-title":"J. Control. Release"},{"key":"2907_CR147","doi-asserted-by":"publisher","first-page":"1657131","DOI":"10.3389\/fimmu.2025.1657131","volume":"16","author":"A Muselman","year":"2025","unstructured":"Muselman, A. et al. Macrophage-targeted PEGylated liposomes ameliorate experimental autoimmune encephalomyelitis. Front. Immunol. 16, 1657131 (2025).","journal-title":"Front. Immunol."},{"key":"2907_CR148","doi-asserted-by":"publisher","first-page":"797","DOI":"10.1038\/gt.2012.100","volume":"20","author":"C Beutner","year":"2013","unstructured":"Beutner, C. et al. Engineered stem cell-derived microglia as therapeutic vehicle for experimental autoimmune encephalomyelitis. Gene Ther. 20, 797\u2013806 (2013).","journal-title":"Gene Ther."},{"key":"2907_CR149","doi-asserted-by":"publisher","first-page":"2107","DOI":"10.1016\/j.ymthe.2018.06.024","volume":"26","author":"G Casella","year":"2018","unstructured":"Casella, G. et al. Extracellular vesicles containing IL-4 modulate neuroinflammation in a mouse model of multiple sclerosis. Mol. Ther. 26, 2107\u20132118 (2018).","journal-title":"Mol. Ther."},{"key":"2907_CR150","doi-asserted-by":"publisher","first-page":"111833","DOI":"10.1016\/j.intimp.2024.111833","volume":"131","author":"Y Yuan","year":"2024","unstructured":"Yuan, Y. et al. Novel insights into macrophage immunometabolism in nonalcoholic steatohepatitis. Int. Immunopharmacol. 131, 111833 (2024).","journal-title":"Int. Immunopharmacol."},{"key":"2907_CR151","first-page":"697","volume":"19","author":"ME Rinella","year":"2023","unstructured":"Rinella, M. E. Examining the nomenclature change from NAFLD and NASH to MASLD and MASH. Nat. Rev. Gastroenterol. Hepatol. 19, 697\u2013699 (2023).","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"2907_CR152","doi-asserted-by":"publisher","first-page":"5260","DOI":"10.7150\/ijbs.73890","volume":"18","author":"N Fan","year":"2022","unstructured":"Fan, N. et al. Covalent inhibition of pyruvate kinase M2 reprograms metabolic and inflammatory pathways in hepatic macrophages against non-alcoholic fatty liver disease. Int. J. Biol. Sci. 18, 5260\u20135275 (2022).","journal-title":"Int. J. Biol. Sci."},{"key":"2907_CR153","doi-asserted-by":"publisher","first-page":"959495","DOI":"10.3389\/fimmu.2022.959495","volume":"13","author":"Y Fan","year":"2022","unstructured":"Fan, Y. et al. Glycyrrhetinic acid regulates impaired macrophage autophagic flux in the treatment of non-alcoholic fatty liver disease. Front. Immunol. 13, 959495 (2022).","journal-title":"Front. Immunol."},{"key":"2907_CR154","doi-asserted-by":"publisher","first-page":"110380","DOI":"10.1016\/j.intimp.2023.110380","volume":"120","author":"Y Yang","year":"2023","unstructured":"Yang, Y. et al. Lapachol treats non-alcoholic fatty liver disease by modulating the M1 polarization of Kupffer cells via PKM2. Int. Immunopharmacol. 120, 110380 (2023).","journal-title":"Int. Immunopharmacol."},{"key":"2907_CR155","doi-asserted-by":"publisher","first-page":"101634","DOI":"10.1016\/j.redox.2020.101634","volume":"36","author":"F Xu","year":"2020","unstructured":"Xu, F. et al. Annexin A5 regulates hepatic macrophage polarization via directly targeting PKM2 and ameliorates NASH. Redox Biol. 36, 101634 (2020).","journal-title":"Redox Biol."},{"key":"2907_CR156","doi-asserted-by":"publisher","first-page":"G387","DOI":"10.1152\/ajpgi.00054.2019","volume":"317","author":"P Zhao","year":"2019","unstructured":"Zhao, P. et al. Digoxin improves steatohepatitis with differential involvement of liver cell subsets in mice through inhibition of PKM2 transactivation. Am. J. Physiol. Gastrointest. Liver Physiol. 317, G387\u2013G397 (2019).","journal-title":"Am. J. Physiol. Gastrointest. Liver Physiol."},{"key":"2907_CR157","doi-asserted-by":"publisher","first-page":"1754","DOI":"10.1002\/hep.29477","volume":"67","author":"SL Friedman","year":"2018","unstructured":"Friedman, S. L. et al. A randomized, placebo-controlled trial of cenicriviroc for treatment of nonalcoholic steatohepatitis with fibrosis. Hepatology 67, 1754\u20131767 (2018).","journal-title":"Hepatology"},{"key":"2907_CR158","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1016\/j.cgh.2023.04.003","volume":"22","author":"QM Anstee","year":"2024","unstructured":"Anstee, Q. M. et al. Cenicriviroc lacked efficacy to treat liver fibrosis in nonalcoholic Steatohepatitis: AURORA phase III randomized study. Clin. Gastroenterol. Hepatol. 22, 124\u2013134.e1 (2024).","journal-title":"Clin. Gastroenterol. Hepatol."},{"key":"2907_CR159","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1016\/j.jconrel.2022.01.038","volume":"343","author":"J-E Zhou","year":"2022","unstructured":"Zhou, J.-E. et al. Hepatic macrophage targeted siRNA lipid nanoparticles treat non-alcoholic steatohepatitis. J. Control. Release 343, 175\u2013186 (2022).","journal-title":"J. Control. Release"},{"key":"2907_CR160","doi-asserted-by":"publisher","first-page":"71","DOI":"10.3389\/fimmu.2012.00071","volume":"3","author":"S Ueha","year":"2012","unstructured":"Ueha, S., Shand, F. H. W. & Matsushima, K. Cellular and molecular mechanisms of chronic inflammation-associated organ fibrosis. Front. Immunol. 3, 71 (2012).","journal-title":"Front. Immunol."},{"key":"2907_CR161","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1097\/HEP.0000000000001160","volume":"84","author":"B Sim\u00f3n-Codina","year":"2026","unstructured":"Sim\u00f3n-Codina, B., Cacho-Pujol, J., Moles, A. & Melgar-Lesmes, P. Reprogramming macrophages to treat liver diseases. Hepatology 84, 251\u2013272 (2026).","journal-title":"Hepatology"},{"key":"2907_CR162","doi-asserted-by":"publisher","first-page":"1265935","DOI":"10.3389\/fphar.2023.1265935","volume":"14","author":"D Ping","year":"2023","unstructured":"Ping, D., Peng, Y., Hu, X. & Liu, C. Macrophage cytotherapy on liver cirrhosis. Front. Pharmacol. 14, 1265935 (2023).","journal-title":"Front. Pharmacol."},{"key":"2907_CR163","doi-asserted-by":"publisher","first-page":"1701","DOI":"10.1002\/stem.3449","volume":"39","author":"S Pouyanfard","year":"2021","unstructured":"Pouyanfard, S. et al. Human induced pluripotent stem cell-derived macrophages ameliorate liver fibrosis. Stem Cells 39, 1701\u20131717 (2021).","journal-title":"Stem Cells"},{"key":"2907_CR164","first-page":"787","volume":"11","author":"L Yao","year":"2023","unstructured":"Yao, L. et al. IGF2-NR4A2 signaling regulates macrophage subtypes to attenuate liver cirrhosis. J. Clin. Transl. Hepatol. 11, 787\u2013799 (2023).","journal-title":"J. Clin. Transl. Hepatol."},{"key":"2907_CR165","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1186\/s12931-018-0864-2","volume":"19","author":"L Zhang","year":"2018","unstructured":"Zhang, L. et al. Macrophages: friend or foe in idiopathic pulmonary fibrosis? Respir. Res. 19, 170 (2018).","journal-title":"Respir. Res."},{"key":"2907_CR166","doi-asserted-by":"publisher","DOI":"10.1002\/btm2.10280","volume":"7","author":"Y Mou","year":"2022","unstructured":"Mou, Y. et al. Macrophage-targeted delivery of siRNA to silence Mecp2 gene expression attenuates pulmonary fibrosis. Bioeng. Transl. Med. 7, e10280 (2022).","journal-title":"Bioeng. Transl. Med."},{"key":"2907_CR167","doi-asserted-by":"publisher","first-page":"613907","DOI":"10.3389\/fimmu.2021.613907","volume":"12","author":"X Sang","year":"2021","unstructured":"Sang, X. et al. Macrophage-targeted lung delivery of dexamethasone improves pulmonary fibrosis therapy via regulating the immune microenvironment. Front. Immunol. 12, 613907 (2021).","journal-title":"Front. Immunol."},{"key":"2907_CR168","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-023-05876-z","volume":"14","author":"S-Y Hong","year":"2023","unstructured":"Hong, S.-Y. et al. Targeting pathogenic macrophages by the application of SHP-1 agonists reduces inflammation and alleviates pulmonary fibrosis. Cell Death Dis. 14, 352 (2023).","journal-title":"Cell Death Dis."},{"key":"2907_CR169","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1186\/s13578-024-01320-7","volume":"14","author":"J-Y Kim","year":"2024","unstructured":"Kim, J.-Y. et al. CXCL11 reprograms M2-biased macrophage polarization to alleviate pulmonary fibrosis in mice. Cell Biosci. 14, 140 (2024).","journal-title":"Cell Biosci."},{"key":"2907_CR170","doi-asserted-by":"publisher","DOI":"10.1002\/btm2.10555","volume":"8","author":"H Liu","year":"2023","unstructured":"Liu, H. et al. Macrophage-based delivery of anti-fibrotic proteins alleviates bleomycin-induced pulmonary fibrosis in mice. Bioeng. Transl. Med. 8, e10555 (2023).","journal-title":"Bioeng. Transl. Med."},{"key":"2907_CR171","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1038\/s41581-019-0110-2","volume":"15","author":"PM-K Tang","year":"2019","unstructured":"Tang, P. M.-K., Nikolic-Paterson, D. J. & Lan, H.-Y. Macrophages: versatile players in renal inflammation and fibrosis. Nat. Rev. Nephrol. 15, 144\u2013158 (2019).","journal-title":"Nat. Rev. Nephrol."},{"key":"2907_CR172","doi-asserted-by":"publisher","first-page":"113947","DOI":"10.1016\/j.biopha.2022.113947","volume":"156","author":"Y-P Lu","year":"2022","unstructured":"Lu, Y.-P. et al. Empagliflozin reduces kidney fibrosis and improves kidney function by alternative macrophage activation in rats with 5\/6-nephrectomy. Biomed. Pharmacother. 156, 113947 (2022).","journal-title":"Biomed. Pharmacother."},{"key":"2907_CR173","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-023-06338-2","volume":"14","author":"L Xie","year":"2023","unstructured":"Xie, L. et al. Activation of GPER1 in macrophages ameliorates UUO-induced renal fibrosis. Cell Death Dis. 14, 818 (2023).","journal-title":"Cell Death Dis."},{"key":"2907_CR174","doi-asserted-by":"publisher","first-page":"826","DOI":"10.1038\/s41423-024-01190-6","volume":"21","author":"Q Ouyang","year":"2024","unstructured":"Ouyang, Q. et al. Depleting profibrotic macrophages using bioactivated in vivo assembly peptides ameliorates kidney fibrosis. Cell Mol. Immunol. 21, 826\u2013841 (2024).","journal-title":"Cell Mol. Immunol."},{"key":"2907_CR175","doi-asserted-by":"crossref","unstructured":"Kim, Y.-A. et al. Synthetic non-coding RNA for suppressing mTOR translation to prevent renal fibrosis related to autophagy in UUO mouse model. Int. J. Mol. Sci. 23 (2022).","DOI":"10.3390\/ijms231911365"},{"key":"2907_CR176","doi-asserted-by":"publisher","first-page":"728","DOI":"10.1007\/s13238-014-0077-5","volume":"5","author":"G Xu","year":"2014","unstructured":"Xu, G., Wang, J., Gao, G. F. & Liu, C. H. Insights into battles between Mycobacterium tuberculosis and macrophages. Protein Cell 5, 728\u2013736 (2014).","journal-title":"Protein Cell"},{"key":"2907_CR177","doi-asserted-by":"publisher","first-page":"768695","DOI":"10.3389\/fimmu.2021.768695","volume":"12","author":"MD Reece","year":"2021","unstructured":"Reece, M. D., Taylor, R. R., Song, C. & Gavegnano, C. Targeting macrophage dysregulation for viral infections: novel targets for immunomodulators. Front. Immunol. 12, 768695 (2021).","journal-title":"Front. Immunol."},{"key":"2907_CR178","doi-asserted-by":"publisher","first-page":"610","DOI":"10.1021\/acsinfecdis.4c00713","volume":"11","author":"RB Bekale","year":"2025","unstructured":"Bekale, R. B. et al. Immunomodulatory nanoparticles induce autophagy in macrophages and reduce mycobacterium tuberculosis burden in the lungs of mice. ACS Infect. Dis. 11, 610\u2013625 (2025).","journal-title":"ACS Infect. Dis."},{"key":"2907_CR179","doi-asserted-by":"publisher","first-page":"1142","DOI":"10.3390\/ijms24021142","volume":"24","author":"D Pires","year":"2023","unstructured":"Pires, D. et al. Liposomal delivery of saquinavir to macrophages overcomes cathepsin blockade by Mycobacterium tuberculosis and helps control the phagosomal replicative niches. Int. J. Mol. Sci. 24, 1142 (2023).","journal-title":"Int. J. Mol. Sci."},{"key":"2907_CR180","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1016\/j.jconrel.2022.02.030","volume":"344","author":"G Li","year":"2022","unstructured":"Li, G. et al. cRGD enables rapid phagocytosis of liposomal vancomycin for intracellular bacterial clearance. J. Control. Release 344, 202\u2013213 (2022).","journal-title":"J. Control. Release"},{"key":"2907_CR181","doi-asserted-by":"publisher","DOI":"10.1002\/cti2.70071","volume":"15","author":"D Paasch","year":"2026","unstructured":"Paasch, D. et al. Immune activation and response dynamics of human iPSC-derived macrophages in tuberculosis infection models. Clin. Transl. Immunol. 15, e70071 (2026).","journal-title":"Clin. Transl. Immunol."},{"key":"2907_CR182","doi-asserted-by":"publisher","first-page":"2261","DOI":"10.1021\/acsnano.3c10109","volume":"18","author":"C Tang","year":"2024","unstructured":"Tang, C. et al. mRNA-laden lipid-nanoparticle-enabled in situ CAR-macrophage engineering for the eradication of multidrug-resistant bacteria in a sepsis mouse model. ACS Nano 18, 2261\u20132278 (2024).","journal-title":"ACS Nano"},{"key":"2907_CR183","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.adg3365","volume":"9","author":"Z Li","year":"2023","unstructured":"Li, Z. et al. Surficial nano-deposition locoregionally yielding bactericidal super CAR-macrophages expedites periprosthetic osseointegration. Sci. Adv. 9, eadg3365 (2023).","journal-title":"Sci. Adv."},{"key":"2907_CR184","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2314747121","volume":"121","author":"G Zhao","year":"2024","unstructured":"Zhao, G. et al. Precision treatment of viral pneumonia through macrophage-targeted lipid nanoparticle delivery. Proc. Natl. Acad. Sci. USA. 121, e2314747121 (2024).","journal-title":"Proc. Natl. Acad. Sci. USA."},{"key":"2907_CR185","doi-asserted-by":"publisher","DOI":"10.1186\/s12951-021-00926-0","volume":"19","author":"Q Tan","year":"2021","unstructured":"Tan, Q. et al. Macrophage biomimetic nanocarriers for anti-inflammation and targeted antiviral treatment in COVID-19. J. Nanobiotechnol. 19, 173 (2021).","journal-title":"J. Nanobiotechnol."},{"key":"2907_CR186","doi-asserted-by":"publisher","first-page":"669103","DOI":"10.3389\/fimmu.2021.669103","volume":"12","author":"W Fu","year":"2021","unstructured":"Fu, W. et al. CAR macrophages for SARS-CoV-2 immunotherapy. Front. Immunol. 12, 669103 (2021).","journal-title":"Front. Immunol."},{"key":"2907_CR187","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1002\/mabi.201600359","volume":"17","author":"H Zazo","year":"2017","unstructured":"Zazo, H. et al. Gold nanocarriers for macrophage-targeted therapy of human immunodeficiency virus. Macromol. Biosci. 17, 3 (2017).","journal-title":"Macromol. Biosci."},{"key":"2907_CR188","doi-asserted-by":"publisher","first-page":"661","DOI":"10.4049\/jimmunol.0900274","volume":"183","author":"H Dou","year":"2009","unstructured":"Dou, H. et al. Macrophage delivery of nanoformulated antiretroviral drug to the brain in a murine model of neuroAIDS. J. Immunol. 183, 661\u2013669 (2009).","journal-title":"J. Immunol."},{"key":"2907_CR189","doi-asserted-by":"publisher","first-page":"801","DOI":"10.1002\/jlb.67.6.801","volume":"67","author":"A van der Goes","year":"2000","unstructured":"van der Goes, A., Hoekstra, K., van den Berg, T. K. & Dijkstra, C. D. Dexamethasone promotes phagocytosis and bacterial killing by human monocytes\/macrophages in vitro. J. Leukoc. Biol. 67, 801\u2013807 (2000).","journal-title":"J. Leukoc. Biol."},{"key":"2907_CR190","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1128\/AAC.50.1.391-395.2006","volume":"50","author":"T Krakauer","year":"2006","unstructured":"Krakauer, T. & Buckley, M. Dexamethasone attenuates staphylococcal enterotoxin B-induced hypothermic response and protects mice from superantigen-induced toxic shock. Antimicrob. Agents Chemother. 50, 391\u2013395 (2006).","journal-title":"Antimicrob. Agents Chemother."},{"key":"2907_CR191","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1056\/NEJMoa2021436","volume":"384","author":"P Horby","year":"2021","unstructured":"Horby, P. et al. Dexamethasone in hospitalized patients with Covid-19. N. Engl. J. Med. 384, 693\u2013704 (2021).","journal-title":"N. Engl. J. Med."},{"key":"2907_CR192","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1038\/nature25986","volume":"556","author":"EL Mills","year":"2018","unstructured":"Mills, E. L. et al. Itaconate is an anti-inflammatory metabolite that activates Nrf2 via alkylation of KEAP1. Nature 556, 113\u2013117 (2018).","journal-title":"Nature"},{"key":"2907_CR193","doi-asserted-by":"publisher","first-page":"9370","DOI":"10.1038\/s41467-025-64407-w","volume":"16","author":"V Yadav","year":"2025","unstructured":"Yadav, V. et al. Bioenergetic reprogramming of macrophages reduces drug tolerance in Mycobacterium tuberculosis. Nat. Commun. 16, 9370 (2025).","journal-title":"Nat. Commun."},{"key":"2907_CR194","doi-asserted-by":"publisher","first-page":"RP102980","DOI":"10.7554\/eLife.102980.3","volume":"13","author":"NV Simwela","year":"2025","unstructured":"Simwela, N. V., Jaecklein, E., Sassetti, C. M. & Russell, D. G. Impaired fatty acid import or catabolism in macrophages restricts intracellular growth of Mycobacterium tuberculosis. eLife 13, RP102980 (2025).","journal-title":"eLife"},{"key":"2907_CR195","doi-asserted-by":"publisher","first-page":"114102","DOI":"10.1016\/j.intimp.2025.114102","volume":"148","author":"X Zhu","year":"2025","unstructured":"Zhu, X. et al. PFKFB3 decreases \u03b1-ketoglutarate production while partial PFKFB3 knockdown in macrophages ameliorates arthritis in tumor necrosis factor-transgenic mice. Int. Immunopharmacol. 148, 114102 (2025).","journal-title":"Int. Immunopharmacol."},{"key":"2907_CR196","doi-asserted-by":"publisher","first-page":"111877","DOI":"10.1016\/j.jocn.2026.111877","volume":"146","author":"R Abolfazli","year":"2026","unstructured":"Abolfazli, R. et al. Longitudinal effects of dimethyl fumarate on patient-reported outcome measures in multiple sclerosis: treatment satisfaction, quality of life, depressive symptoms, sleep, and work productivity. J. Clin. Neurosci. 146, 111877 (2026).","journal-title":"J. Clin. Neurosci."},{"key":"2907_CR197","doi-asserted-by":"publisher","first-page":"1114897","DOI":"10.3389\/fphar.2023.1114897","volume":"14","author":"Y Zhang","year":"2023","unstructured":"Zhang, Y. et al. Short-term exposure to dimethyl fumarate (DMF) inhibits LPS-induced I\u03baB\u03b6 expression in macrophages. Front. Pharm. 14, 1114897 (2023).","journal-title":"Front. Pharm."},{"key":"2907_CR198","doi-asserted-by":"publisher","first-page":"vkaf289","DOI":"10.1093\/jimmun\/vkaf289","volume":"215","author":"D R Lima","year":"2026","unstructured":"Lima, D. R. et al. Dimethyl fumarate protects from experimental autoimmune encephalomyelitis by modulating colonic immune cells. J. Immunol. 215, vkaf289 (2026).","journal-title":"J. Immunol."},{"key":"2907_CR199","doi-asserted-by":"publisher","first-page":"103676","DOI":"10.1016\/j.redox.2025.103676","volume":"84","author":"S Kourakis","year":"2025","unstructured":"Kourakis, S. et al. Repurposed Nrf2 activator dimethyl fumarate rescues muscle inflammation and fibrosis in an aggravated mdx mouse model of Duchenne muscular dystrophy. Redox Biol. 84, 103676 (2025).","journal-title":"Redox Biol."},{"key":"2907_CR200","doi-asserted-by":"publisher","first-page":"7884","DOI":"10.1074\/jbc.M113.522037","volume":"289","author":"AJ Freemerman","year":"2014","unstructured":"Freemerman, A. J. et al. Metabolic reprogramming of macrophages: glucose transporter 1 (GLUT1)-mediated glucose metabolism drives a proinflammatory phenotype. J. Biol. Chem. 289, 7884\u20137896 (2014).","journal-title":"J. Biol. Chem."},{"key":"2907_CR201","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.adg0654","volume":"9","author":"Y-J Chen","year":"2023","unstructured":"Chen, Y.-J. et al. Targeting IRG1 reverses the immunosuppressive function of tumor-associated macrophages and enhances cancer immunotherapy. Sci. Adv. 9, eadg0654 (2023).","journal-title":"Sci. Adv."},{"key":"2907_CR202","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1038\/s41556-025-01839-y","volume":"28","author":"D Li","year":"2026","unstructured":"Li, D. et al. Inhibiting macrophage-derived lactate transport restores cGAS-STING signalling and enhances antitumour immunity in glioblastoma. Nat. Cell Biol. 28, 349\u2013362 (2026).","journal-title":"Nat. Cell Biol."},{"key":"2907_CR203","doi-asserted-by":"publisher","DOI":"10.1002\/adma.202311109","volume":"36","author":"Y Dong","year":"2024","unstructured":"Dong, Y. et al. Intracavitary spraying of nanoregulator-encased hydrogel modulates cholesterol metabolism of glioma-supportive macrophage for postoperative glioblastoma immunotherapy. Adv. Mater. 36, e2311109 (2024).","journal-title":"Adv. Mater."},{"key":"2907_CR204","doi-asserted-by":"publisher","first-page":"1654","DOI":"10.1016\/j.celrep.2017.07.054","volume":"20","author":"EM Palmieri","year":"2017","unstructured":"Palmieri, E. M. et al. Pharmacologic or genetic targeting of glutamine synthetase skews macrophages toward an M1-like phenotype and inhibits tumor metastasis. Cell Rep. 20, 1654\u20131666 (2017).","journal-title":"Cell Rep."},{"key":"2907_CR205","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1186\/s40425-017-0308-4","volume":"5","author":"SM Steggerda","year":"2017","unstructured":"Steggerda, S. M. et al. Inhibition of arginase by CB-1158 blocks myeloid cell-mediated immune suppression in the tumor microenvironment. J. ImmunoTher. Cancer 5, 101 (2017).","journal-title":"J. ImmunoTher. Cancer"},{"key":"2907_CR206","doi-asserted-by":"publisher","first-page":"115658","DOI":"10.1016\/j.bmc.2020.115658","volume":"28","author":"B Borek","year":"2020","unstructured":"Borek, B., Gajda, T., Golebiowski, A. & Blaszczyk, R. Boronic acid-based arginase inhibitors in cancer immunotherapy. Bioorg. Med. Chem. 28, 115658 (2020).","journal-title":"Bioorg. Med. Chem."},{"key":"2907_CR207","doi-asserted-by":"publisher","first-page":"703465","DOI":"10.3389\/fonc.2021.703465","volume":"11","author":"P Pilanc","year":"2021","unstructured":"Pilanc, P. et al. A novel oral arginase 1\/2 inhibitor enhances the antitumor effect of PD-1 inhibition in murine experimental gliomas by altering the immunosuppressive environment. Front. Oncol. 11, 703465 (2021).","journal-title":"Front. Oncol."},{"key":"2907_CR208","doi-asserted-by":"publisher","first-page":"11149","DOI":"10.1002\/cam4.5698","volume":"12","author":"Q Wang","year":"2023","unstructured":"Wang, Q. et al. Role of tumor microenvironment in cancer progression and therapeutic strategy. Cancer Med. 12, 11149\u201311165 (2023).","journal-title":"Cancer Med."},{"key":"2907_CR209","doi-asserted-by":"publisher","first-page":"e001341","DOI":"10.1136\/jitc-2020-001341","volume":"9","author":"C Li","year":"2021","unstructured":"Li, C. et al. Tumor-associated macrophages: potential therapeutic strategies and future prospects in cancer. J. Immunother. Cancer 9, e001341 (2021).","journal-title":"J. Immunother. Cancer"},{"key":"2907_CR210","doi-asserted-by":"publisher","first-page":"28","DOI":"10.3390\/vaccines4030028","volume":"4","author":"B Chaudhary","year":"2016","unstructured":"Chaudhary, B. & Elkord, E. Regulatory T cells in the tumor microenvironment and cancer progression: role and therapeutic targeting. Vaccines 4, 28 (2016).","journal-title":"Vaccines"},{"key":"2907_CR211","doi-asserted-by":"publisher","first-page":"3356","DOI":"10.1172\/JCI80005","volume":"125","author":"D Marvel","year":"2015","unstructured":"Marvel, D. & Gabrilovich, D. I. Myeloid-derived suppressor cells in the tumor microenvironment: expect the unexpected. J. Clin. Investig. 125, 3356\u20133364 (2015).","journal-title":"J. Clin. Investig."},{"key":"2907_CR212","doi-asserted-by":"publisher","first-page":"1919082","DOI":"10.1155\/2019\/1919082","volume":"2019","author":"D Lu","year":"2019","unstructured":"Lu, D. et al. Beyond T cells: understanding the role of PD-1\/PD-L1 in tumor-associated macrophages. J. Immunol. Res. 2019, 1919082 (2019).","journal-title":"J. Immunol. Res."},{"key":"2907_CR213","doi-asserted-by":"publisher","first-page":"1199173","DOI":"10.3389\/fimmu.2023.1199173","volume":"14","author":"Y-L Yang","year":"2023","unstructured":"Yang, Y.-L. et al. T cells, NK cells, and tumor-associated macrophages in cancer immunotherapy and the current state of the art of drug delivery systems. Front. Immunol. 14, 1199173 (2023).","journal-title":"Front. Immunol."},{"key":"2907_CR214","doi-asserted-by":"publisher","first-page":"153303382110363","DOI":"10.1177\/15330338211036304","volume":"20","author":"Y Li","year":"2021","unstructured":"Li, Y., Zhao, L. & Li, X.-F. Hypoxia and the tumor microenvironment. Technol. Cancer Res. Treat. 20, 15330338211036304 (2021).","journal-title":"Technol. Cancer Res. Treat."},{"key":"2907_CR215","doi-asserted-by":"publisher","first-page":"927329","DOI":"10.3389\/fendo.2022.927329","volume":"13","author":"X Wei","year":"2022","unstructured":"Wei, X., Hou, Y., Long, M., Jiang, L. & Du, Y. Molecular mechanisms underlying the role of hypoxia-inducible factor-1 \u03b1 in metabolic reprogramming in renal fibrosis. Front. Endocrinol. 13, 927329 (2022).","journal-title":"Front. Endocrinol."},{"key":"2907_CR216","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1038\/s41392-023-01332-8","volume":"8","author":"Z Chen","year":"2023","unstructured":"Chen, Z., Han, F., Du, Y., Shi, H. & Zhou, W. Hypoxic microenvironment in cancer: molecular mechanisms and therapeutic interventions. Signal Transduct. Target. Ther. 8, 70 (2023).","journal-title":"Signal Transduct. Target. Ther."},{"key":"2907_CR217","doi-asserted-by":"publisher","first-page":"428","DOI":"10.1080\/15384101.2018.1444305","volume":"17","author":"X Mu","year":"2018","unstructured":"Mu, X. et al. Tumor-derived lactate induces M2 macrophage polarization via the activation of the ERK\/STAT3 signaling pathway in breast cancer. Cell Cycle 17, 428\u2013438 (2018).","journal-title":"Cell Cycle"},{"key":"2907_CR218","doi-asserted-by":"publisher","first-page":"1319","DOI":"10.1038\/s41590-018-0226-8","volume":"19","author":"T Bohn","year":"2018","unstructured":"Bohn, T. et al. Tumor immunoevasion via acidosis-dependent induction of regulatory tumor-associated macrophages. Nat. Immunol. 19, 1319\u20131329 (2018).","journal-title":"Nat. Immunol."},{"key":"2907_CR219","doi-asserted-by":"publisher","first-page":"668349","DOI":"10.3389\/fonc.2021.668349","volume":"11","author":"G Gunaydin","year":"2021","unstructured":"Gunaydin, G. CAFs interacting With TAMs in tumor microenvironment to enhance tumorigenesis and immune evasion. Front. Oncol. 11, 668349 (2021).","journal-title":"Front. Oncol."},{"key":"2907_CR220","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1186\/s40164-025-00647-2","volume":"14","author":"M Zhang","year":"2025","unstructured":"Zhang, M. & Zhang, B. Extracellular matrix stiffness: mechanisms in tumor progression and therapeutic potential in cancer. Exp. Hematol. Oncol. 14, 54 (2025).","journal-title":"Exp. Hematol. Oncol."},{"key":"2907_CR221","doi-asserted-by":"publisher","first-page":"1467602","DOI":"10.3389\/fimmu.2024.1467602","volume":"15","author":"X Feng","year":"2024","unstructured":"Feng, X. et al. Targeting extracellular matrix stiffness for cancer therapy. Front. Immunol. 15, 1467602 (2024).","journal-title":"Front. Immunol."},{"key":"2907_CR222","doi-asserted-by":"publisher","DOI":"10.1186\/s12885-020-07697-1","volume":"20","author":"C Tekin","year":"2020","unstructured":"Tekin, C., Aberson, H. L., Bijlsma, M. F. & Spek, C. A. Early macrophage infiltrates impair pancreatic cancer cell growth by TNF-\u03b1 secretion. BMC Cancer 20, 1183 (2020).","journal-title":"BMC Cancer"},{"key":"2907_CR223","doi-asserted-by":"publisher","first-page":"100862","DOI":"10.1016\/j.tranon.2020.100862","volume":"13","author":"C-Y Huang","year":"2020","unstructured":"Huang, C.-Y., Ye, Z.-H., Huang, M.-Y. & Lu, J.-J. Regulation of CD47 expression in cancer cells. Transl. Oncol. 13, 100862 (2020).","journal-title":"Transl. Oncol."},{"issue":"Suppl 4","key":"2907_CR224","first-page":"A1264","volume":"12","author":"PR Smith","year":"2024","unstructured":"Smith, P. R. et al. 1142 Generation of tumor-killing iPSC-macrophages through the genetic interrogation of CD47-SIRPa don\u2019t eat me receptor pathway. J. Immunother. Cancer 12(Suppl 4), A1264 (2024).","journal-title":"J. Immunother. Cancer"},{"issue":"Suppl 2","key":"2907_CR225","first-page":"A1740","volume":"11","author":"K Haake","year":"2023","unstructured":"Haake, K. et al. 1515 Gene edited iPSC-derived macrophages (iMACs) show increased phagocytosis in pre-clinical tumor models. J. Immunother. Cancer 11(Suppl 2), A1740 (2023).","journal-title":"J. Immunother. Cancer"},{"key":"2907_CR226","doi-asserted-by":"publisher","first-page":"1225","DOI":"10.1002\/JLB.3MIA0917-352R","volume":"103","author":"JP Taylor","year":"2018","unstructured":"Taylor, J. P. et al. CRISPR\/Cas9 knockout of USP18 enhances type I IFN responsiveness and restricts HIV-1 infection in macrophages. J. Leukoc. Biol. 103, 1225\u20131240 (2018).","journal-title":"J. Leukoc. Biol."},{"key":"2907_CR227","doi-asserted-by":"publisher","first-page":"626","DOI":"10.1016\/j.immuni.2018.03.037","volume":"48","author":"K Ganesh","year":"2018","unstructured":"Ganesh, K. & Massagu\u00e9, J. TGF-\u03b2 Inhibition and Immunotherapy: checkmate. Immunity 48, 626\u2013628 (2018).","journal-title":"Immunity"},{"key":"2907_CR228","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1016\/j.semcancer.2019.12.007","volume":"65","author":"SK Daniel","year":"2020","unstructured":"Daniel, S. K., Seo, Y. D. & Pillarisetty, V. G. The CXCL12-CXCR4\/CXCR7 axis as a mechanism of immune resistance in gastrointestinal malignancies. Semin. Cancer Biol. 65, 176\u2013188 (2020).","journal-title":"Semin. Cancer Biol."},{"key":"2907_CR229","doi-asserted-by":"publisher","first-page":"e008431","DOI":"10.1136\/jitc-2023-008431","volume":"12","author":"S Wang","year":"2024","unstructured":"Wang, S., Li, Y., Xu, C., Dong, J. & Wei, J. An oncolytic vaccinia virus encoding hyaluronidase reshapes the extracellular matrix to enhance cancer chemotherapy and immunotherapy. J. Immunother. Cancer 12, e008431 (2024).","journal-title":"J. Immunother. Cancer"},{"key":"2907_CR230","doi-asserted-by":"publisher","first-page":"2033","DOI":"10.1016\/j.cell.2021.02.048","volume":"184","author":"S Kaczanowska","year":"2021","unstructured":"Kaczanowska, S. et al. Genetically engineered myeloid cells rebalance the core immune suppression program in metastasis. Cell 184, 2033\u20132052.e21 (2021).","journal-title":"Cell"},{"key":"2907_CR231","doi-asserted-by":"publisher","first-page":"101204","DOI":"10.1016\/j.omtm.2024.101204","volume":"32","author":"B Kang","year":"2024","unstructured":"Kang, B. et al. Large-scale generation of IL-12 secreting macrophages from human pluripotent stem cells for cancer therapy. Mol. Ther. Methods Clin. Dev. 32, 101204 (2024).","journal-title":"Mol. Ther. Methods Clin. Dev."},{"key":"2907_CR232","doi-asserted-by":"publisher","first-page":"14589","DOI":"10.1073\/pnas.251451498","volume":"98","author":"M Wu","year":"2001","unstructured":"Wu, M. et al. Genetically engineered macrophages expressing IFN-gamma restore alveolar immune function in scid mice. Proc. Natl. Acad. Sci. USA. 98, 14589\u201314594 (2001).","journal-title":"Proc. Natl. Acad. Sci. USA."},{"key":"2907_CR233","doi-asserted-by":"publisher","first-page":"e001356","DOI":"10.1136\/jitc-2020-001356","volume":"8","author":"KJ Brempelis","year":"2020","unstructured":"Brempelis, K. J. et al. Genetically engineered macrophages persist in solid tumors and locally deliver therapeutic proteins to activate immune responses. J. Immunother. Cancer 8, e001356 (2020).","journal-title":"J. Immunother. Cancer"},{"key":"2907_CR234","doi-asserted-by":"publisher","first-page":"6201728","DOI":"10.1155\/2024\/6201728","volume":"2024","author":"M Klimak","year":"2024","unstructured":"Klimak, M. & Guilak, F. Genetically engineered macrophages derived from iPSCs for self-regulating delivery of anti-inflammatory biologic drugs. J. Tissue Eng. Regen. Med. 2024, 6201728 (2024).","journal-title":"J. Tissue Eng. Regen. Med."},{"key":"2907_CR235","doi-asserted-by":"publisher","first-page":"697","DOI":"10.1016\/j.jconrel.2024.02.003","volume":"367","author":"P Ning","year":"2024","unstructured":"Ning, P. et al. Genetically engineered macrophages as living cell drug carriers for targeted cancer therapy. J. Control. Release 367, 697\u2013707 (2024).","journal-title":"J. Control. Release"},{"key":"2907_CR236","doi-asserted-by":"publisher","DOI":"10.1186\/s12951-024-02369-9","volume":"22","author":"H Zhang","year":"2024","unstructured":"Zhang, H. et al. Genetically engineered membrane-based nanoengagers for immunotherapy of pancreatic cancer. J. Nanobiotechnol. 22, 104 (2024).","journal-title":"J. Nanobiotechnol."},{"key":"2907_CR237","doi-asserted-by":"publisher","first-page":"6136","DOI":"10.1021\/acssensors.4c01997","volume":"9","author":"T Wang","year":"2024","unstructured":"Wang, T. et al. SynNotch-programmed macrophages for cancerous cell detection and sensing. ACS Sens. 9, 6136\u20136147 (2024).","journal-title":"ACS Sens."},{"key":"2907_CR238","first-page":"3876","volume":"13","author":"S Semeniuk","year":"2024","unstructured":"Semeniuk, S., Qian, B.-Z. & Cachat, E. Engineering an \u03b1CD206-synNotch receptor: insights into the development of novel synthetic receptors. ACS Sens 13, 3876\u20133884 (2024).","journal-title":"ACS Sens"},{"key":"2907_CR239","doi-asserted-by":"publisher","first-page":"e178146","DOI":"10.1172\/jci.insight.178146","volume":"10","author":"T Sato","year":"2025","unstructured":"Sato, T. et al. Sustained inhibition of CSF1R signaling augments antitumor immunity through inhibiting tumor-associated macrophages. JCI Insight 10, e178146 (2025).","journal-title":"JCI Insight"},{"key":"2907_CR240","doi-asserted-by":"publisher","first-page":"578","DOI":"10.1038\/s41551-018-0236-8","volume":"2","author":"CB Rodell","year":"2018","unstructured":"Rodell, C. B. et al. TLR7\/8-agonist-loaded nanoparticles promote the polarization of tumour-associated macrophages to enhance cancer immunotherapy. Nat. Biomed. Eng. 2, 578\u2013588 (2018).","journal-title":"Nat. Biomed. Eng."},{"key":"2907_CR241","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1159\/000518664","volume":"8","author":"L Tian","year":"2022","unstructured":"Tian, L. et al. Macrophage-based combination therapies as a new strategy for cancer immunotherapy. Kidney Dis. 8, 26\u201343 (2022).","journal-title":"Kidney Dis."},{"key":"2907_CR242","doi-asserted-by":"publisher","DOI":"10.34133\/bmr.0023","volume":"28","author":"M Li","year":"2024","unstructured":"Li, M. et al. Biomaterial-based CRISPR\/Cas9 delivery systems for tumor treatment. Biomater. Res. 28, 23 (2024).","journal-title":"Biomater. Res."},{"key":"2907_CR243","doi-asserted-by":"publisher","first-page":"2272","DOI":"10.1007\/s13346-025-01970-1","volume":"16","author":"S G\u00fcl","year":"2025","unstructured":"G\u00fcl, S., Vergnaud, J., Fay, F. & Fattal, E. Precision engineering of macrophage reprogramming with RNA interference-loaded lipid nanoparticles: a game-changer in cancer immunotherapy. Drug Deliv. Transl. Res. 16, 2272\u20132301 (2025).","journal-title":"Drug Deliv. Transl. Res."},{"key":"2907_CR244","doi-asserted-by":"publisher","first-page":"2486","DOI":"10.1039\/D3SC06431J","volume":"15","author":"X Zhang","year":"2024","unstructured":"Zhang, X. et al. Polarization of macrophages to an anti-cancer phenotype through in situ uncaging of a TLR 7\/8 agonist using bioorthogonal nanozymes. Chem. Sci. 15, 2486\u20132494 (2024).","journal-title":"Chem. Sci."},{"key":"2907_CR245","doi-asserted-by":"publisher","first-page":"334","DOI":"10.1039\/D5NH00351B","volume":"11","author":"L Yue","year":"2026","unstructured":"Yue, L., Gao, X., Qi, W., Zhang, L. & Wang, Y. Optimizing the targeting of lipid nanoparticles for gene therapy. Nanoscale Horiz. 11, 334\u2013356 (2026).","journal-title":"Nanoscale Horiz."},{"key":"2907_CR246","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1007\/s00262-025-04105-0","volume":"74","author":"J Lakshmipathi","year":"2025","unstructured":"Lakshmipathi, J. et al. Intratumoral IL12 mRNA administration activates innate and adaptive pathways in checkpoint inhibitor-resistant tumors resulting in complete responses. Cancer Immunol. Immunother. 74, 250 (2025).","journal-title":"Cancer Immunol. Immunother."},{"key":"2907_CR247","doi-asserted-by":"publisher","first-page":"17549","DOI":"10.1021\/acsnano.1c04456","volume":"15","author":"AA Walters","year":"2021","unstructured":"Walters, A. A. et al. Nanoparticle-mediated in situ molecular reprogramming of immune checkpoint interactions for cancer immunotherapy. ACS Nano 15, 17549\u201317564 (2021).","journal-title":"ACS Nano"},{"key":"2907_CR248","doi-asserted-by":"publisher","first-page":"1895","DOI":"10.1016\/j.ymthe.2024.03.035","volume":"32","author":"S Ganesh","year":"2024","unstructured":"Ganesh, S. et al. RNAi mediated silencing of STAT3\/PD-L1 in tumor-associated immune cells induces robust anti-tumor effects in immunotherapy resistant tumors. Mol. Ther. 32, 1895\u20131916 (2024).","journal-title":"Mol. Ther."},{"key":"2907_CR249","doi-asserted-by":"publisher","first-page":"102357","DOI":"10.1016\/j.omtn.2024.102357","volume":"35","author":"C Zhang","year":"2024","unstructured":"Zhang, C. et al. Local CpG-Stat3 siRNA treatment improves antitumor effects of immune checkpoint inhibitors. Mol. Ther. Nucleic Acids 35, 102357 (2024).","journal-title":"Mol. Ther. Nucleic Acids"},{"key":"2907_CR250","doi-asserted-by":"publisher","first-page":"839","DOI":"10.1016\/j.bbi.2019.05.034","volume":"80","author":"DM Lamkin","year":"2019","unstructured":"Lamkin, D. M. et al. C\/EBP\u03b2 regulates the M2 transcriptome in \u03b2-adrenergic-stimulated macrophages. Brain Behav. Immun. 80, 839\u2013848 (2019).","journal-title":"Brain Behav. Immun."},{"key":"2907_CR251","doi-asserted-by":"publisher","first-page":"1514595","DOI":"10.3389\/fcell.2024.1514595","volume":"12","author":"Y Liu","year":"2024","unstructured":"Liu, Y. et al. Hydrogel systems for spatiotemporal controlled delivery of immunomodulators: engineering the tumor immune microenvironment for enhanced cancer immunotherapy. Front. Cell Dev. Biol. 12, 1514595 (2024).","journal-title":"Front. Cell Dev. Biol."},{"key":"2907_CR252","doi-asserted-by":"publisher","first-page":"3081","DOI":"10.1007\/s10439-025-03823-x","volume":"53","author":"SR Henriques","year":"2025","unstructured":"Henriques, S. R. et al. Locally reprogramming tumor-associated macrophages with cytokine-loaded injectable cryogels for breast cancer. Ann. Biomed. Eng. 53, 3081\u20133095 (2025).","journal-title":"Ann. Biomed. Eng."},{"key":"2907_CR253","doi-asserted-by":"publisher","first-page":"1257","DOI":"10.1039\/D1BM01835C","volume":"10","author":"Y Liu","year":"2022","unstructured":"Liu, Y. et al. Injectable hydrogel platform with biodegradable Dawson-type polyoxometalate and R848 for combinational photothermal-immunotherapy of cancer. Biomater. Sci. 10, 1257\u20131266 (2022).","journal-title":"Biomater. Sci."},{"key":"2907_CR254","doi-asserted-by":"publisher","first-page":"20315","DOI":"10.1021\/acsami.8b04312","volume":"10","author":"Z Sun","year":"2018","unstructured":"Sun, Z. et al. Injectable hydrogels coencapsulating granulocyte-macrophage colony-stimulating factor and ovalbumin nanoparticles to enhance antigen uptake efficiency. ACS Appl. Mater. Interfaces 10, 20315\u201320325 (2018).","journal-title":"ACS Appl. Mater. Interfaces"},{"key":"2907_CR255","doi-asserted-by":"publisher","first-page":"113897","DOI":"10.1016\/j.jconrel.2025.113897","volume":"384","author":"C Kuwentrai","year":"2025","unstructured":"Kuwentrai, C. et al. Injectable hydrogel-based drug formulation for enhancing tertiary lymphoid structure formation and cancer immunotherapy efficacy. J. Control. Release 384, 113897 (2025).","journal-title":"J. Control. Release"},{"key":"2907_CR256","doi-asserted-by":"publisher","first-page":"1529","DOI":"10.1038\/s41375-018-0106-0","volume":"32","author":"MC Milone","year":"2018","unstructured":"Milone, M. C. & O\u2019Doherty, U. Clinical use of lentiviral vectors. Leukemia 32, 1529\u20131541 (2018).","journal-title":"Leukemia"},{"key":"2907_CR257","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1038\/mt.2009.319","volume":"18","author":"J M\u00e1trai","year":"2010","unstructured":"M\u00e1trai, J., Chuah, M. K. L. & VandenDriessche, T. Recent advances in lentiviral vector development and applications. Mol. Ther. 18, 477\u2013490 (2010).","journal-title":"Mol. Ther."},{"key":"2907_CR258","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-024-55770-1","volume":"16","author":"S Pierini","year":"2025","unstructured":"Pierini, S. et al. Chimeric antigen receptor macrophages (CAR-M) sensitize HER2+ solid tumors to PD1 blockade in pre-clinical models. Nat. Commun. 16, 706 (2025).","journal-title":"Nat. Commun."},{"key":"2907_CR259","doi-asserted-by":"publisher","first-page":"762","DOI":"10.4049\/jimmunol.164.2.762","volume":"164","author":"A Sica","year":"2000","unstructured":"Sica, A. et al. Autocrine production of IL-10 mediates defective IL-12 production and NF-kappa B activation in tumor-associated macrophages. J. Immunol. 164, 762\u2013767 (2000).","journal-title":"J. Immunol."},{"key":"2907_CR260","doi-asserted-by":"publisher","first-page":"2876","DOI":"10.1038\/s41388-018-0600-x","volume":"38","author":"JS Fletcher","year":"2019","unstructured":"Fletcher, J. S. et al. STAT3 inhibition reduces macrophage number and tumor growth in neurofibroma. Oncogene 38, 2876\u20132884 (2019).","journal-title":"Oncogene"},{"key":"2907_CR261","doi-asserted-by":"publisher","first-page":"670","DOI":"10.3389\/fimmu.2020.00670","volume":"11","author":"G Ronzitti","year":"2020","unstructured":"Ronzitti, G., Gross, D.-A. & Mingozzi, F. Human Immune Responses to Adeno-Associated Virus (AAV) Vectors. Front. Immunol. 11, 670 (2020).","journal-title":"Front. Immunol."},{"key":"2907_CR262","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2302997120","volume":"120","author":"A Young","year":"2023","unstructured":"Young, A. et al. Targeted evolution of adeno-associated virus capsids for systemic transgene delivery to microglia and tissue-resident macrophages. Proc. Natl. Acad. Sci. USA. 120, e2302997120 (2023).","journal-title":"Proc. Natl. Acad. Sci. USA."},{"key":"2907_CR263","doi-asserted-by":"publisher","first-page":"353","DOI":"10.2147\/BTT.S326422","volume":"15","author":"M Asmamaw","year":"2021","unstructured":"Asmamaw, M. & Zawdie, B. Mechanism and applications of CRISPR\/Cas-9-mediated genome editing. Biol. Targets Ther. 15, 353\u2013361 (2021).","journal-title":"Biol. Targets Ther."},{"key":"2907_CR264","doi-asserted-by":"publisher","first-page":"201002","DOI":"10.1016\/j.omton.2025.201002","volume":"33","author":"C Chen","year":"2025","unstructured":"Chen, C. et al. Tumor-specific AAV delivery of interleukin-12 enhances antitumor immunity and safety in ovarian cancer xenograft mouse model. Mol. Ther. Oncol. 33, 201002 (2025).","journal-title":"Mol. Ther. Oncol."},{"key":"2907_CR265","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1016\/j.canlet.2009.05.024","volume":"286","author":"LF He","year":"2009","unstructured":"He, L. F. et al. Suppression of cancer growth in mice by adeno-associated virus vector-mediated IFN-beta expression driven by hTERT promoter. Cancer Lett. 286, 196\u2013205 (2009).","journal-title":"Cancer Lett."},{"key":"2907_CR266","doi-asserted-by":"publisher","first-page":"430","DOI":"10.2174\/156652308786848012","volume":"8","author":"C Sarkis","year":"2008","unstructured":"Sarkis, C., Philippe, S., Mallet, J. & Serguera, C. Non-integrating lentiviral vectors. Curr. Gene Ther. 8, 430\u2013437 (2008).","journal-title":"Curr. Gene Ther."},{"key":"2907_CR267","doi-asserted-by":"publisher","first-page":"17684","DOI":"10.1073\/pnas.0606197103","volume":"103","author":"S Philippe","year":"2006","unstructured":"Philippe, S. et al. Lentiviral vectors with a defective integrase allow efficient and sustained transgene expression in vitro and in vivo. Proc. Natl. Acad. Sci. USA. 103, 17684\u201317689 (2006).","journal-title":"Proc. Natl. Acad. Sci. USA."},{"key":"2907_CR268","doi-asserted-by":"publisher","first-page":"1182","DOI":"10.1038\/s41590-025-02191-x","volume":"26","author":"G Marelli","year":"2025","unstructured":"Marelli, G. et al. Chemosensor receptors are lipid-detecting regulators of macrophage function in cancer. Nat. Immunol. 26, 1182\u20131197 (2025).","journal-title":"Nat. Immunol."},{"key":"2907_CR269","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1002\/jlb.64.4.419","volume":"64","author":"R Andreesen","year":"1998","unstructured":"Andreesen, R., Hennemann, B. & Krause, S. W. Adoptive immunotherapy of cancer using monocyte-derived macrophages: rationale, current status, and perspectives. J. Leukoc. Biol. 64, 419\u2013426 (1998).","journal-title":"J. Leukoc. Biol."},{"key":"2907_CR270","doi-asserted-by":"publisher","first-page":"eaaz3223","DOI":"10.1126\/sciadv.aaz3223","volume":"6","author":"SE Lindner","year":"2020","unstructured":"Lindner, S. E., Johnson, S. M., Brown, C. E. & Wang, L. D. Chimeric antigen receptor signaling: functional consequences and design implications. Sci. Adv. 6, eaaz3223 (2020).","journal-title":"Sci. Adv."},{"key":"2907_CR271","doi-asserted-by":"publisher","first-page":"545","DOI":"10.1056\/NEJMoa1910607","volume":"382","author":"E Liu","year":"2020","unstructured":"Liu, E. et al. Use of CAR-transduced natural killer cells in CD19-positive lymphoid tumors. N. Engl. J. Med. 382, 545\u2013553 (2020).","journal-title":"N. Engl. J. Med."},{"key":"2907_CR272","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1186\/s13045-021-01083-5","volume":"14","author":"Y Gong","year":"2021","unstructured":"Gong, Y., Klein Wolterink, R. G. J., Wang, J., Bos, G. M. J. & Germeraad, W. T. V. Chimeric antigen receptor natural killer (CAR-NK) cell design and engineering for cancer therapy. J. Hematol. Oncol. 14, 73 (2021).","journal-title":"J. Hematol. Oncol."},{"key":"2907_CR273","doi-asserted-by":"publisher","first-page":"994","DOI":"10.3390\/cells11060994","volume":"11","author":"D Paasch","year":"2022","unstructured":"Paasch, D. et al. Ex vivo generation of CAR macrophages from hematopoietic stem and progenitor cells for use in cancer therapy. Cells 11, 994 (2022).","journal-title":"Cells"},{"key":"2907_CR274","doi-asserted-by":"publisher","first-page":"1171","DOI":"10.1038\/s41591-025-03495-z","volume":"31","author":"KA Reiss","year":"2025","unstructured":"Reiss, K. A. et al. CAR-macrophage therapy for HER2-overexpressing advanced solid tumors: a phase 1 trial. Nat. Med. 31, 1171\u20131182 (2025).","journal-title":"Nat. Med."},{"key":"2907_CR275","doi-asserted-by":"publisher","first-page":"1277","DOI":"10.1038\/sj.emboj.7600594","volume":"24","author":"BN Gantner","year":"2005","unstructured":"Gantner, B. N., Simmons, R. M. & Underhill, D. M. Dectin-1 mediates macrophage recognition of Candida albicans yeast but not filaments. EMBO J. 24, 1277\u20131286 (2005).","journal-title":"EMBO J."},{"key":"2907_CR276","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1038\/nri3582","volume":"14","author":"M Guilliams","year":"2014","unstructured":"Guilliams, M., Bruhns, P., Saeys, Y., Hammad, H. & Lambrecht, B. N. The function of Fc\u03b3 receptors in dendritic cells and macrophages. Nat. Rev. Immunol. 14, 94\u2013108 (2014).","journal-title":"Nat. Rev. Immunol."},{"key":"2907_CR277","doi-asserted-by":"publisher","first-page":"731","DOI":"10.1038\/s41591-018-0041-7","volume":"24","author":"T Giavridis","year":"2018","unstructured":"Giavridis, T. et al. CAR T cell-induced cytokine release syndrome is mediated by macrophages and abated by IL-1 blockade. Nat. Med. 24, 731\u2013738 (2018).","journal-title":"Nat. Med."},{"key":"2907_CR278","doi-asserted-by":"publisher","first-page":"947","DOI":"10.1038\/s41587-020-0462-y","volume":"38","author":"M Klichinsky","year":"2020","unstructured":"Klichinsky, M. et al. Human chimeric antigen receptor macrophages for cancer immunotherapy. Nat. Biotechnol. 38, 947\u2013953 (2020).","journal-title":"Nat. Biotechnol."},{"key":"2907_CR279","doi-asserted-by":"publisher","first-page":"e002741","DOI":"10.1136\/jitc-2021-002741","volume":"9","author":"SM Abdin","year":"2021","unstructured":"Abdin, S. M., Paasch, D., Morgan, M. & Lachmann, N. CARs and beyond: tailoring macrophage-based cell therapeutics to combat solid malignancies. J. Immunother. Cancer 9, e002741 (2021).","journal-title":"J. Immunother. Cancer"},{"key":"2907_CR280","doi-asserted-by":"publisher","first-page":"837","DOI":"10.1038\/s41416-019-0578-3","volume":"121","author":"W Zhang","year":"2019","unstructured":"Zhang, W. et al. Chimeric antigen receptor macrophage therapy for breast tumours mediated by targeting the tumour extracellular matrix. Br. J. Cancer 121, 837\u2013845 (2019).","journal-title":"Br. J. Cancer"},{"key":"2907_CR281","doi-asserted-by":"publisher","first-page":"e007705","DOI":"10.1136\/jitc-2023-007705","volume":"11","author":"SM Abdin","year":"2023","unstructured":"Abdin, S. M. et al. Scalable generation of functional human iPSC-derived CAR-macrophages that efficiently eradicate CD19-positive leukemia. J. Immunother. Cancer 11, e007705 (2023).","journal-title":"J. Immunother. Cancer"},{"key":"2907_CR282","doi-asserted-by":"publisher","first-page":"3201","DOI":"10.4049\/jimmunol.1400330","volume":"194","author":"K T\u00f6pfer","year":"2015","unstructured":"T\u00f6pfer, K. et al. DAP12-based activating chimeric antigen receptor for NK cell tumor immunotherapy. J. Immunol. 194, 3201\u20133212 (2015).","journal-title":"J. Immunol."},{"key":"2907_CR283","doi-asserted-by":"publisher","first-page":"S198","DOI":"10.1016\/j.jcyt.2025.03.401","volume":"27","author":"MH dos Santos","year":"2025","unstructured":"dos Santos, M. H. et al. Enhancing anti-CD19 CAR-NK cytotoxicity via 2B4 Co-stimulation and dasatinib modulation. Cytotherapy 27, S198 (2025).","journal-title":"Cytotherapy"},{"key":"2907_CR284","doi-asserted-by":"publisher","first-page":"101931","DOI":"10.1016\/j.xcrm.2025.101931","volume":"6","author":"T Look","year":"2025","unstructured":"Look, T. et al. CAR T cells, CAR NK cells, and CAR macrophages exhibit distinct traits in glioma models but are similarly enhanced when combined with cytokines. Cell Rep. Med. 6, 101931 (2025).","journal-title":"Cell Rep. Med."},{"key":"2907_CR285","doi-asserted-by":"crossref","unstructured":"Morrissey, M. A. et al. Chimeric antigen receptors that trigger phagocytosis. eLife 7, e36688 (2018).","DOI":"10.7554\/eLife.36688"},{"key":"2907_CR286","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1038\/s41421-024-00718-4","volume":"10","author":"Z Gao","year":"2024","unstructured":"Gao, Z. et al. Targeting cardiac fibrosis with chimeric antigen receptor macrophages. Cell Discov. 10, 86 (2024).","journal-title":"Cell Discov."},{"key":"2907_CR287","doi-asserted-by":"publisher","first-page":"vdaf059","DOI":"10.1093\/noajnl\/vdaf059","volume":"7","author":"MJA Koppers","year":"2025","unstructured":"Koppers, M. J. A., Monnikhof, M., Meeldijk, J., Koorman, T. & Bovenschen, N. Chimeric antigen receptor-macrophages: emerging next-generation cell therapy for brain cancer. Neuro-Oncol. Adv. 7, vdaf059 (2025).","journal-title":"Neuro-Oncol. Adv."},{"key":"2907_CR288","doi-asserted-by":"publisher","first-page":"2124","DOI":"10.1038\/s41591-022-02017-5","volume":"28","author":"A Mackensen","year":"2022","unstructured":"Mackensen, A. et al. Anti-CD19 CAR T cell therapy for refractory systemic lupus erythematosus. Nat. Med. 28, 2124\u20132132 (2022).","journal-title":"Nat. Med."},{"key":"2907_CR289","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1126\/science.aaf6756","volume":"353","author":"CT Ellebrecht","year":"2016","unstructured":"Ellebrecht, C. T. et al. Reengineering chimeric antigen receptor T cells for targeted therapy of autoimmune disease. Science 353, 179\u2013184 (2016).","journal-title":"Science"},{"key":"2907_CR290","doi-asserted-by":"publisher","first-page":"e167215","DOI":"10.1172\/jci.insight.167215","volume":"8","author":"I Rosado-S\u00e1nchez","year":"2023","unstructured":"Rosado-S\u00e1nchez, I. et al. Tregs integrate native and CAR-mediated costimulatory signals for control of allograft rejection. JCI Insight 8, e167215 (2023).","journal-title":"JCI Insight"},{"key":"2907_CR291","doi-asserted-by":"publisher","first-page":"1502","DOI":"10.1038\/s41551-025-01387-8","volume":"9","author":"Q Cao","year":"2025","unstructured":"Cao, Q. et al. Targeting inflammation with chimeric antigen receptor macrophages using a signal switch. Nat. Biomed. Eng. 9, 1502\u20131516 (2025).","journal-title":"Nat. Biomed. Eng."},{"key":"2907_CR292","doi-asserted-by":"publisher","first-page":"1431","DOI":"10.1016\/j.cell.2022.03.023","volume":"185","author":"I Zhu","year":"2022","unstructured":"Zhu, I. et al. Modular design of synthetic receptors for programmed gene regulation in cell therapies. Cell 185, 1431\u20131443.e16 (2022).","journal-title":"Cell"},{"key":"2907_CR293","doi-asserted-by":"publisher","first-page":"847","DOI":"10.1038\/nbt.4195","volume":"36","author":"S Rafiq","year":"2018","unstructured":"Rafiq, S. et al. Targeted delivery of a PD-1-blocking scFv by CAR-T cells enhances anti-tumor efficacy in vivo. Nat. Biotechnol. 36, 847\u2013856 (2018).","journal-title":"Nat. Biotechnol."},{"key":"2907_CR294","doi-asserted-by":"publisher","first-page":"1049","DOI":"10.1038\/s41587-019-0192-1","volume":"37","author":"BD Choi","year":"2019","unstructured":"Choi, B. D. et al. CAR-T cells secreting BiTEs circumvent antigen escape without detectable toxicity. Nat. Biotechnol. 37, 1049\u20131058 (2019).","journal-title":"Nat. Biotechnol."},{"key":"2907_CR295","doi-asserted-by":"crossref","unstructured":"Liu, M. et al. CAR-macrophages and CAR-T cells synergistically kill tumor cells in vitro. Cells 11, 3692 (2022).","DOI":"10.3390\/cells11223692"},{"key":"2907_CR296","doi-asserted-by":"publisher","first-page":"838","DOI":"10.1038\/s43018-025-00950-1","volume":"6","author":"W Jing","year":"2025","unstructured":"Jing, W. et al. An in situ engineered chimeric IL-2 receptor potentiates the tumoricidal activity of proinflammatory CAR macrophages in renal cell carcinoma. Nat. Cancer 6, 838\u2013853 (2025).","journal-title":"Nat. Cancer"},{"key":"2907_CR297","doi-asserted-by":"publisher","first-page":"743","DOI":"10.1038\/s43018-025-00912-7","volume":"6","author":"D Bas\u00edlio-Queir\u00f3s","year":"2025","unstructured":"Bas\u00edlio-Queir\u00f3s, D. & Lachmann, N. In vivo macrophage engineering for renal cancer therapy. Nat. Cancer 6, 743\u2013745 (2025).","journal-title":"Nat. Cancer"},{"key":"2907_CR298","doi-asserted-by":"publisher","first-page":"803","DOI":"10.1016\/j.stem.2024.03.018","volume":"31","author":"Z Shah","year":"2024","unstructured":"Shah, Z. et al. Human anti-PSCA CAR macrophages possess potent antitumor activity against pancreatic cancer. Cell Stem Cell 31, 803\u2013817.e6 (2024).","journal-title":"Cell Stem Cell"},{"key":"2907_CR299","doi-asserted-by":"publisher","first-page":"791","DOI":"10.1016\/j.stem.2024.05.006","volume":"31","author":"D Paasch","year":"2024","unstructured":"Paasch, D. & Lachmann, N. CAR macrophages tuning the immune symphony of anti-cancer therapies. Cell Stem Cell 31, 791\u2013793 (2024).","journal-title":"Cell Stem Cell"},{"key":"2907_CR300","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1038\/s41590-023-01687-8","volume":"25","author":"A Lei","year":"2024","unstructured":"Lei, A. et al. A second-generation M1-polarized CAR macrophage with antitumor efficacy. Nat. Immunol. 25, 102\u2013116 (2024).","journal-title":"Nat. Immunol."},{"key":"2907_CR301","doi-asserted-by":"publisher","first-page":"1194","DOI":"10.1126\/science.abq0225","volume":"378","author":"KG Daniels","year":"2022","unstructured":"Daniels, K. G. et al. Decoding CAR T cell phenotype using combinatorial signaling motif libraries and machine learning. Science 378, 1194\u20131200 (2022).","journal-title":"Science"},{"key":"2907_CR302","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1007\/978-1-59745-396-7_9","volume":"531","author":"X Zhang","year":"2009","unstructured":"Zhang, X., Edwards, J. P. & Mosser, D. M. The expression of exogenous genes in macrophages: obstacles and opportunities. Methods Mol. Biol. 531, 123\u2013143 (2009).","journal-title":"Methods Mol. Biol."},{"key":"2907_CR303","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1189\/jlb.72.3.417","volume":"72","author":"B Burke","year":"2002","unstructured":"Burke, B., Sumner, S., Maitland, N. & Lewis, C. E. Macrophages in gene therapy: cellular delivery vehicles and in vivo targets. J. Leukoc. Biol. 72, 417\u2013428 (2002).","journal-title":"J. Leukoc. Biol."},{"key":"2907_CR304","doi-asserted-by":"publisher","first-page":"752","DOI":"10.1038\/s41587-024-02282-4","volume":"43","author":"L Peng","year":"2024","unstructured":"Peng, L. et al. In vivo AAV-SB-CRISPR screens of tumor-infiltrating primary NK cells identify genetic checkpoints of CAR-NK therapy. Nat. Biotechnol. 43, 752\u2013761 (2024).","journal-title":"Nat. Biotechnol."},{"key":"2907_CR305","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2310221120","volume":"120","author":"AK Mishra","year":"2023","unstructured":"Mishra, A. K. et al. Hyperactive Rac stimulates cannibalism of living target cells and enhances CAR-M-mediated cancer cell killing. Proc. Natl. Acad. Sci. USA. 120, e2310221120 (2023).","journal-title":"Proc. Natl. Acad. Sci. USA."},{"key":"2907_CR306","doi-asserted-by":"crossref","unstructured":"Miller, W. D. et al. CD47 inhibits phagocytosis through Vav dephosphorylation. J. Cell Biol. 224, e202502206 (2025).","DOI":"10.1083\/jcb.202502206"},{"key":"2907_CR307","doi-asserted-by":"publisher","first-page":"626","DOI":"10.1038\/s41586-024-07018-7","volume":"626","author":"J Garcia","year":"2024","unstructured":"Garcia, J. et al. Naturally occurring T cell mutations enhance engineered T cell therapies. Nature 626, 626\u2013634 (2024).","journal-title":"Nature"},{"key":"2907_CR308","doi-asserted-by":"publisher","first-page":"1125","DOI":"10.1016\/j.jaci.2023.11.914","volume":"153","author":"X Liu","year":"2024","unstructured":"Liu, X. et al. Recapitulating primary immunodeficiencies with expanded potential stem cells: Proof of concept with STAT1 gain of function. J. Allergy Clin. Immunol. 153, 1125\u20131139 (2024).","journal-title":"J. Allergy Clin. Immunol."},{"key":"2907_CR309","doi-asserted-by":"publisher","first-page":"842","DOI":"10.1038\/s41591-021-01326-5","volume":"27","author":"N Singh","year":"2021","unstructured":"Singh, N. et al. Antigen-independent activation enhances the efficacy of 4-1BB-costimulated CD22 CAR T cells. Nat. Med. 27, 842\u2013850 (2021).","journal-title":"Nat. Med."},{"key":"2907_CR310","doi-asserted-by":"publisher","first-page":"2372","DOI":"10.1016\/j.cell.2025.03.017","volume":"188","author":"T Kondo","year":"2025","unstructured":"Kondo, T. et al. Engineering TCR-controlled fuzzy logic into CAR T cells enhances therapeutic specificity. Cell 188, 2372\u20132389.e35 (2025).","journal-title":"Cell"},{"key":"2907_CR311","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1158\/2326-6066.CIR-22-0504","volume":"11","author":"X Chen","year":"2023","unstructured":"Chen, X. et al. Rational Protein Design Yields a CD20 CAR with Superior Antitumor Efficacy Compared with CD19 CAR. Cancer Immunol. Res. 11, 150\u2013163 (2023).","journal-title":"Cancer Immunol. Res."},{"key":"2907_CR312","doi-asserted-by":"publisher","first-page":"702","DOI":"10.1038\/s41586-024-07762-w","volume":"634","author":"Z Bai","year":"2024","unstructured":"Bai, Z. et al. Single-cell CAR T atlas reveals type 2 function in 8-year leukaemia remission. Nature 634, 702\u2013711 (2024).","journal-title":"Nature"},{"key":"2907_CR313","doi-asserted-by":"publisher","first-page":"712","DOI":"10.1038\/s41586-024-07962-4","volume":"634","author":"B Feng","year":"2024","unstructured":"Feng, B. et al. The type 2 cytokine Fc-IL-4 revitalizes exhausted CD8+ T cells against cancer. Nature 634, 712\u2013720 (2024).","journal-title":"Nature"},{"key":"2907_CR314","doi-asserted-by":"publisher","first-page":"e175015","DOI":"10.1172\/jci.insight.175015","volume":"9","author":"AB Kim","year":"2024","unstructured":"Kim, A. B. et al. Chimeric antigen receptor macrophages target and resorb amyloid plaques. JCI Insight 9, e175015 (2024).","journal-title":"JCI Insight"},{"key":"2907_CR315","doi-asserted-by":"publisher","first-page":"718","DOI":"10.1016\/j.jconrel.2023.07.021","volume":"360","author":"Z Yang","year":"2023","unstructured":"Yang, Z. et al. Dual mRNA co-delivery for in situ generation of phagocytosis-enhanced CAR macrophages augments hepatocellular carcinoma immunotherapy. J. Control. Release 360, 718\u2013733 (2023).","journal-title":"J. Control. Release"},{"key":"2907_CR316","doi-asserted-by":"publisher","first-page":"660","DOI":"10.1016\/j.tem.2024.08.009","volume":"36","author":"X Wang","year":"2025","unstructured":"Wang, X., Zhang, S., Xue, D., Neculai, D. & Zhang, J. Metabolic reprogramming of macrophages in cancer therapy. Trends Endocrinol. Metab. 36, 660\u2013676 (2025).","journal-title":"Trends Endocrinol. Metab."},{"key":"2907_CR317","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1038\/s41590-018-0292-y","volume":"20","author":"M Liu","year":"2019","unstructured":"Liu, M. et al. Metabolic rewiring of macrophages by CpG potentiates clearance of cancer cells and overcomes tumor-expressed CD47-mediated \u2018don\u2019t-eat-me\u2019 signal. Nat. Immunol. 20, 265\u2013275 (2019).","journal-title":"Nat. Immunol."},{"key":"2907_CR318","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-023-41470-9","volume":"14","author":"X Wang","year":"2023","unstructured":"Wang, X. et al. Metabolic Reprogramming via ACOD1 depletion enhances function of human induced pluripotent stem cell-derived CAR-macrophages in solid tumors. Nat. Commun. 14, 5778 (2023).","journal-title":"Nat. Commun."},{"key":"2907_CR319","doi-asserted-by":"publisher","first-page":"1320","DOI":"10.1016\/j.immuni.2023.05.008","volume":"56","author":"AE Baxter","year":"2023","unstructured":"Baxter, A. E. et al. The SWI\/SNF chromatin remodeling complexes BAF and PBAF differentially regulate epigenetic transitions in exhausted CD8+ T cells. Immunity 56, 1320\u20131340.e10 (2023).","journal-title":"Immunity"},{"key":"2907_CR320","doi-asserted-by":"publisher","DOI":"10.1126\/science.adf1329","volume":"384","author":"D Mathew","year":"2024","unstructured":"Mathew, D. et al. Combined JAK inhibition and PD-1 immunotherapy for non-small cell lung cancer patients. Science 384, eadf1329 (2024).","journal-title":"Science"},{"key":"2907_CR321","doi-asserted-by":"publisher","first-page":"1378944","DOI":"10.3389\/fimmu.2024.1378944","volume":"15","author":"L Levstek","year":"2024","unstructured":"Levstek, L., Jan\u017ei\u010d, L., Ihan, A. & Kopitar, A. N. Biomarkers for prediction of CAR T therapy outcomes: current and future perspectives. Front. Immunol. 15, 1378944 (2024).","journal-title":"Front. Immunol."},{"key":"2907_CR322","doi-asserted-by":"publisher","first-page":"633","DOI":"10.1016\/S0531-5565(97)00094-6","volume":"32","author":"D Danon","year":"1997","unstructured":"Danon, D. et al. Treatment of human ulcers by application of macrophages prepared from a blood unit. Exp. Gerontol. 32, 633\u2013641 (1997).","journal-title":"Exp. Gerontol."},{"key":"2907_CR323","doi-asserted-by":"publisher","first-page":"1461","DOI":"10.3727\/096368915X690279","volume":"25","author":"ER Chernykh","year":"2016","unstructured":"Chernykh, E. R. et al. Safety and Therapeutic Potential of M2 Macrophages in Stroke Treatment. Cell Transplant. 25, 1461\u20131471 (2016).","journal-title":"Cell Transplant."},{"key":"2907_CR324","doi-asserted-by":"publisher","first-page":"101180","DOI":"10.1016\/j.omtm.2023.101180","volume":"32","author":"M O\u2019Callaghan","year":"2024","unstructured":"O\u2019Callaghan, M. & McCarthy, C. Pulmonary macrophage transplant therapy in parenchymal lung diseases. Mol. Ther. Methods Clin. Dev. 32, 101180 (2024).","journal-title":"Mol. Ther. Methods Clin. Dev."},{"key":"2907_CR325","doi-asserted-by":"publisher","first-page":"849","DOI":"10.1016\/j.jcyt.2024.12.002","volume":"27","author":"DT Rodgers","year":"2025","unstructured":"Rodgers, D. T., Novobrantseva, T. & Barcia, R. N. Smart Cell Therapy: an industry perspective on macrophages as living drugs. Cytotherapy 27, 849\u2013863 (2025).","journal-title":"Cytotherapy"},{"key":"2907_CR326","doi-asserted-by":"publisher","first-page":"1945","DOI":"10.1038\/s12276-023-01068-z","volume":"55","author":"YR Na","year":"2023","unstructured":"Na, Y. R., Kim, S. W. & Seok, S. H. A new era of macrophage-based cell therapy. Exp. Mol. Med. 55, 1945\u20131954 (2023).","journal-title":"Exp. Mol. Med."},{"key":"2907_CR327","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1007\/BF01756597","volume":"33","author":"A Faradji","year":"1991","unstructured":"Faradji, A. et al. Phase I trial of intravenous infusion of ex-vivo-activated autologous blood-derived macrophages in patients with non-small-cell lung cancer: toxicity and immunomodulatory effects. Cancer Immunol. Immunother. 33, 319\u2013326 (1991).","journal-title":"Cancer Immunol. Immunother."},{"key":"2907_CR328","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1002\/jgm.543","volume":"6","author":"M Nilsson","year":"2004","unstructured":"Nilsson, M. et al. Development of an adenoviral vector system with adenovirus serotype 35 tropism; efficient transient gene transfer into primary malignant hematopoietic cells. J. Gene Med. 6, 631\u2013641 (2004).","journal-title":"J. Gene Med."},{"key":"2907_CR329","doi-asserted-by":"publisher","first-page":"1003","DOI":"10.1016\/j.stem.2024.04.012","volume":"31","author":"J Shen","year":"2024","unstructured":"Shen, J. et al. Activating innate immune responses repolarizes hPSC-derived CAR macrophages to improve anti-tumor activity. Cell Stem Cell 31, 1003\u20131019.e9 (2024).","journal-title":"Cell Stem Cell"},{"key":"2907_CR330","doi-asserted-by":"publisher","first-page":"2590","DOI":"10.1097\/CM9.0000000000002944","volume":"137","author":"B Yang","year":"2024","unstructured":"Yang, B., Wang, X., Wei, X. & Ma, J. Development of a novel HER2-CAR monocyte cell therapy with controllable proliferation and enhanced anti-tumor efficacy. Chin. Med. J. 137, 2590\u20132602 (2024).","journal-title":"Chin. Med. J."},{"key":"2907_CR331","doi-asserted-by":"publisher","first-page":"1359","DOI":"10.1016\/S0140-6736(21)01374-X","volume":"398","author":"P Gin\u00e8s","year":"2021","unstructured":"Gin\u00e8s, P. et al. Liver cirrhosis. Lancet 398, 1359\u20131376 (2021).","journal-title":"Lancet"},{"key":"2907_CR332","doi-asserted-by":"publisher","DOI":"10.1136\/bmjgast-2016-000079","volume":"3","author":"H Li","year":"2016","unstructured":"Li, H., You, H., Fan, X. & Jia, J. Hepatic macrophages in liver fibrosis: pathogenesis and potential therapeutic targets. BMJ Open Gastroenterol. 3, e000079 (2016).","journal-title":"BMJ Open Gastroenterol."},{"key":"2907_CR333","doi-asserted-by":"publisher","first-page":"6542","DOI":"10.1073\/pnas.1302168110","volume":"110","author":"TG Bird","year":"2013","unstructured":"Bird, T. G. et al. Bone marrow injection stimulates hepatic ductular reactions in the absence of injury via macrophage-mediated TWEAK signaling. Proc. Natl. Acad. Sci. USA. 110, 6542\u20136547 (2013).","journal-title":"Proc. Natl. Acad. Sci. USA."},{"key":"2907_CR334","doi-asserted-by":"publisher","first-page":"2003","DOI":"10.1002\/hep.24315","volume":"53","author":"JA Thomas","year":"2011","unstructured":"Thomas, J. A. et al. Macrophage therapy for murine liver fibrosis recruits host effector cells improving fibrosis, regeneration, and function. Hepatology 53, 2003\u20132015 (2011).","journal-title":"Hepatology"},{"key":"2907_CR335","doi-asserted-by":"publisher","first-page":"1560","DOI":"10.1038\/s41591-019-0599-8","volume":"5","author":"F Moroni","year":"2019","unstructured":"Moroni, F. et al. Safety profile of autologous macrophage therapy for liver cirrhosis. Nat. Med. 5, 1560\u20131565 (2019).","journal-title":"Nat. Med."},{"key":"2907_CR336","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2021-053190","volume":"11","author":"PN Brennan","year":"2021","unstructured":"Brennan, P. N. et al. Study protocol: a multicentre, open-label, parallel-group, phase 2, randomised controlled trial of autologous macrophage therapy for liver cirrhosis (MATCH). BMJ Open 11, e053190 (2021).","journal-title":"BMJ Open"},{"key":"2907_CR337","doi-asserted-by":"publisher","first-page":"S81","DOI":"10.1016\/S0168-8278(24)00574-9","volume":"80","author":"P Brennan","year":"2024","unstructured":"Brennan, P. et al. LBP-007 Beneficial effects of autologous macrophage therapy on clinical outcomes in patients with compensated cirrhosis: extended follow-up data from a randomized controlled phase 2 trial. J. Hepatol. 80, S81 (2024).","journal-title":"J. Hepatol."},{"key":"2907_CR338","doi-asserted-by":"publisher","first-page":"735","DOI":"10.1038\/s41591-025-03490-4","volume":"31","author":"JJ Maher","year":"2025","unstructured":"Maher, J. J. Not the end of the road for macrophage therapy in liver cirrhosis. Nat. Med. 31, 735\u2013736 (2025).","journal-title":"Nat. Med."},{"key":"2907_CR339","doi-asserted-by":"publisher","first-page":"S186","DOI":"10.1016\/S0168-8278(24)00801-8","volume":"80","author":"N Aleksieva","year":"2024","unstructured":"Aleksieva, N. et al. WED-090 Developing a discovery platform for engineered macrophage cell therapies for end stage liver disease. J. Hepatol. 80, S186\u2013S187 (2024).","journal-title":"J. Hepatol."},{"issue":"Suppl 4","key":"2907_CR340","first-page":"A57.2","volume":"74","author":"J Fallowfield","year":"2025","unstructured":"Fallowfield, J. et al. P68 An open-label phase 1\/2 multicentre study to evaluate the safety, tolerability and efficacy of RTX001 autologous macrophages in participants with liver cirrhosis who have hepatic decompensation (EMERALD). Gut 74(Suppl 4), A57.2\u2013A58 (2025).","journal-title":"Gut"},{"key":"2907_CR341","doi-asserted-by":"publisher","first-page":"115713","DOI":"10.1016\/j.addr.2025.115713","volume":"227","author":"D Bas\u00edlio-Queir\u00f3s","year":"2025","unstructured":"Bas\u00edlio-Queir\u00f3s, D., Rivi\u00e8re, I., van der Stegen, S. J. C. & Lachmann, N. iPSC-derived T cells and macrophages: Manufacturing and next-generation application approaches. Adv. Drug Deliv. Rev. 227, 115713 (2025).","journal-title":"Adv. Drug Deliv. Rev."},{"key":"2907_CR342","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.adr4058","volume":"17","author":"M Sun","year":"2025","unstructured":"Sun, M. et al. Adoptive cell therapy with macrophage-drug conjugates facilitates cytotoxic drug transfer and immune activation in glioblastoma models. Sci. Transl. Med. 17, eadr4058 (2025).","journal-title":"Sci. Transl. Med."},{"key":"2907_CR343","doi-asserted-by":"publisher","first-page":"5752","DOI":"10.4049\/jimmunol.1103426","volume":"188","author":"DC Lacey","year":"2012","unstructured":"Lacey, D. C. et al. Defining GM-CSF- and macrophage-CSF-dependent macrophage responses by in vitro models. J. Immunol. 188, 5752\u20135765 (2012).","journal-title":"J. Immunol."},{"key":"2907_CR344","doi-asserted-by":"publisher","first-page":"1113","DOI":"10.1016\/j.jcyt.2017.05.009","volume":"19","author":"AR Fraser","year":"2017","unstructured":"Fraser, A. R. et al. Development, functional characterization and validation of methodology for GMP-compliant manufacture of phagocytic macrophages: a novel cellular therapeutic for liver cirrhosis. Cytotherapy 19, 1113\u20131124 (2017).","journal-title":"Cytotherapy"},{"key":"2907_CR345","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1016\/j.jim.2018.09.012","volume":"463","author":"M Erdmann","year":"2018","unstructured":"Erdmann, M. et al. Automated closed-system manufacturing of human monocyte-derived dendritic cells for cancer immunotherapy. J. Immunol. Methods 463, 89\u201396 (2018).","journal-title":"J. Immunol. Methods"},{"key":"2907_CR346","first-page":"55","volume":"109","author":"JDM Campbell","year":"2005","unstructured":"Campbell, J. D. M. et al. Isolation and generation of clinical-grade dendritic cells using the CliniMACS system. Methods Mol. Med. 109, 55\u201370 (2005).","journal-title":"Methods Mol. Med."},{"key":"2907_CR347","doi-asserted-by":"publisher","first-page":"1349","DOI":"10.1016\/j.jcyt.2023.07.012","volume":"25","author":"N Trainor","year":"2023","unstructured":"Trainor, N. et al. Automated production of gene-modified chimeric antigen receptor T cells using the Cocoon Platform. Cytotherapy 25, 1349\u20131360 (2023).","journal-title":"Cytotherapy"},{"key":"2907_CR348","doi-asserted-by":"publisher","first-page":"2488","DOI":"10.1002\/bit.27088","volume":"116","author":"E Costariol","year":"2019","unstructured":"Costariol, E. et al. Establishing the scalable manufacture of primary human T-cells in an automated stirred-tank bioreactor. Biotechnol. Bioeng. 116, 2488\u20132502 (2019).","journal-title":"Biotechnol. Bioeng."},{"key":"2907_CR349","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1016\/j.jim.2006.07.028","volume":"318","author":"C Lemarie","year":"2007","unstructured":"Lemarie, C. et al. Purification of monocytes from cryopreserved mobilized apheresis products by elutriation with the Elutra device. J. Immunol. Methods 318, 30\u201336 (2007).","journal-title":"J. Immunol. Methods"},{"key":"2907_CR350","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1089\/152581603322448222","volume":"12","author":"J Babatz","year":"2003","unstructured":"Babatz, J. et al. Large-scale immunomagnetic selection of CD14+ monocytes to generate dendritic cells for cancer immunotherapy: a phase I study. J. Hematother. Stem Cell Res. 12, 515\u2013523 (2003).","journal-title":"J. Hematother. Stem Cell Res."},{"key":"2907_CR351","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1016\/j.virol.2009.05.027","volume":"390","author":"SM Bol","year":"2009","unstructured":"Bol, S. M. et al. Donor variation in in vitro HIV-1 susceptibility of monocyte-derived macrophages. Virology 390, 205\u2013211 (2009).","journal-title":"Virology"},{"key":"2907_CR352","doi-asserted-by":"publisher","first-page":"1798","DOI":"10.3389\/fimmu.2017.01798","volume":"8","author":"S Xu","year":"2017","unstructured":"Xu, S. & Shinohara, M. L. Tissue-resident macrophages in fungal infections. Front. Immunol. 8, 1798 (2017).","journal-title":"Front. Immunol."},{"key":"2907_CR353","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1054\/tuld.2000.0247","volume":"80","author":"S Atkinson","year":"2000","unstructured":"Atkinson, S., Valadas, E., Smith, S. M., Lukey, P. T. & Dockrell, H. M. Monocyte-derived macrophage cytokine responses induced by M. bovis BCG. Tuber. Lung Dis. 80, 197\u2013207 (2000).","journal-title":"Tuber. Lung Dis."},{"key":"2907_CR354","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1111\/imm.13125","volume":"159","author":"MC Nielsen","year":"2020","unstructured":"Nielsen, M. C., Andersen, M. N. & M\u00f8ller, H. J. Monocyte isolation techniques significantly impact the phenotype of both isolated monocytes and derived macrophages in vitro. Immunology 159, 63\u201374 (2020).","journal-title":"Immunology"},{"key":"2907_CR355","doi-asserted-by":"publisher","first-page":"1604","DOI":"10.1016\/j.jcyt.2015.07.016","volume":"17","author":"JK Moore","year":"2015","unstructured":"Moore, J. K. et al. Phenotypic and functional characterization of macrophages with therapeutic potential generated from human cirrhotic monocytes in a cohort study. Cytotherapy 17, 1604\u20131616 (2015).","journal-title":"Cytotherapy"},{"key":"2907_CR356","doi-asserted-by":"publisher","first-page":"1399","DOI":"10.3389\/fonc.2020.01399","volume":"10","author":"M Kiss","year":"2020","unstructured":"Kiss, M., Caro, A. A., Raes, G. & Laoui, D. Systemic reprogramming of monocytes in cancer. Front. Oncol. 10, 1399 (2020).","journal-title":"Front. Oncol."},{"key":"2907_CR357","doi-asserted-by":"publisher","first-page":"1199273","DOI":"10.3389\/fimmu.2023.1199273","volume":"14","author":"H Liu","year":"2023","unstructured":"Liu, H., Wang, Z., Zhou, Y. & Yang, Y. MDSCs in breast cancer: an important enabler of tumor progression and an emerging therapeutic target. Front. Immunol. 14, 1199273 (2023).","journal-title":"Front. Immunol."},{"key":"2907_CR358","doi-asserted-by":"publisher","first-page":"815","DOI":"10.1016\/j.immuni.2014.09.014","volume":"41","author":"M Chittezhath","year":"2014","unstructured":"Chittezhath, M. et al. Molecular profiling reveals a tumor-promoting phenotype of monocytes and macrophages in human cancer progression. Immunity 41, 815\u2013829 (2014).","journal-title":"Immunity"},{"key":"2907_CR359","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1186\/s13578-022-00824-4","volume":"12","author":"I Lyadova","year":"2022","unstructured":"Lyadova, I. & Vasiliev, A. Macrophages derived from pluripotent stem cells: prospective applications and research gaps. Cell Biosci. 12, 96 (2022).","journal-title":"Cell Biosci."},{"key":"2907_CR360","doi-asserted-by":"publisher","first-page":"753","DOI":"10.1038\/nn.4534","volume":"20","author":"H Pandya","year":"2017","unstructured":"Pandya, H. et al. Differentiation of human and murine induced pluripotent stem cells to microglia-like cells. Nat. Neurosci. 20, 753\u2013759 (2017).","journal-title":"Nat. Neurosci."},{"key":"2907_CR361","doi-asserted-by":"crossref","unstructured":"Klepikova, A. et al. iPSC-derived macrophages: the differentiation protocol affects cell immune characteristics and differentiation trajectories. Int. J. Mol. Sci. 23, 16087 (2022).","DOI":"10.3390\/ijms232416087"},{"key":"2907_CR362","doi-asserted-by":"publisher","first-page":"4808","DOI":"10.3390\/ijms21134808","volume":"21","author":"S Gutbier","year":"2020","unstructured":"Gutbier, S. et al. Large-scale production of human iPSC-derived macrophages for drug screening. Int. J. Mol. Sci. 21, 4808 (2020).","journal-title":"Int. J. Mol. Sci."},{"key":"2907_CR363","doi-asserted-by":"crossref","unstructured":"Hai, Q. et al. Optimized method to generate well-characterized macrophages from induced pluripotent stem cells. Biomedicines 13, 99 (2025).","DOI":"10.3390\/biomedicines13010099"},{"key":"2907_CR364","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1038\/s41596-021-00654-7","volume":"17","author":"M Ackermann","year":"2022","unstructured":"Ackermann, M. et al. Continuous human iPSC-macrophage mass production by suspension culture in stirred tank bioreactors. Nat. Protoc. 17, 513\u2013539 (2022).","journal-title":"Nat. Protoc."},{"key":"2907_CR365","doi-asserted-by":"publisher","first-page":"572","DOI":"10.1038\/nprot.2011.325","volume":"6","author":"M Amit","year":"2011","unstructured":"Amit, M. et al. Dynamic suspension culture for scalable expansion of undifferentiated human pluripotent stem cells. Nat. Protoc. 6, 572\u2013579 (2011).","journal-title":"Nat. Protoc."},{"key":"2907_CR366","doi-asserted-by":"publisher","first-page":"1289","DOI":"10.5966\/sctm.2015-0253","volume":"5","author":"C Kropp","year":"2016","unstructured":"Kropp, C. et al. Impact of feeding strategies on the scalable expansion of human pluripotent stem cells in single-use stirred tank bioreactors. Stem Cells Transl. Med. 5, 1289\u20131301 (2016).","journal-title":"Stem Cells Transl. Med."},{"key":"2907_CR367","doi-asserted-by":"publisher","first-page":"1063","DOI":"10.1002\/sctm.20-0453","volume":"10","author":"F Manstein","year":"2021","unstructured":"Manstein, F. et al. High density bioprocessing of human pluripotent stem cells by metabolic control and in silico modeling. Stem Cells Transl. Med. 10, 1063\u20131080 (2021).","journal-title":"Stem Cells Transl. Med."},{"key":"2907_CR368","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1186\/s13287-024-03699-z","volume":"15","author":"K Ullmann","year":"2024","unstructured":"Ullmann, K. et al. Matrix-free human pluripotent stem cell manufacturing by seed train approach and intermediate cryopreservation. Stem Cell Res. Ther. 15, 89 (2024).","journal-title":"Stem Cell Res. Ther."},{"key":"2907_CR369","doi-asserted-by":"publisher","first-page":"898","DOI":"10.1093\/stcltm\/szae047","volume":"13","author":"D Terheyden-Keighley","year":"2024","unstructured":"Terheyden-Keighley, D. et al. GMP-compliant iPS cell lines show widespread plasticity in a new set of differentiation workflows for cell replacement and cancer immunotherapy. Stem Cells Transl. Med. 13, 898\u2013911 (2024).","journal-title":"Stem Cells Transl. Med."},{"key":"2907_CR370","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1007\/978-1-0716-3437-0_2","volume":"2713","author":"A Ahlback","year":"2024","unstructured":"Ahlback, A. & Gentek, R. Fate-mapping macrophages: from ontogeny to functions. Methods Mol. Biol. 2713, 11\u201343 (2024).","journal-title":"Methods Mol. Biol."},{"key":"2907_CR371","doi-asserted-by":"publisher","first-page":"1282","DOI":"10.1016\/j.stemcr.2019.05.003","volume":"12","author":"X Cao","year":"2019","unstructured":"Cao, X. et al. Differentiation and functional comparison of monocytes and macrophages from hiPSCs with peripheral blood derivatives. Stem Cell Rep. 12, 1282\u20131297 (2019).","journal-title":"Stem Cell Rep."},{"key":"2907_CR372","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-022-30557-4","volume":"13","author":"C Alsinet","year":"2022","unstructured":"Alsinet, C. et al. Robust temporal map of human in vitro myelopoiesis using single-cell genomics. Nat. Commun. 13, 2885 (2022).","journal-title":"Nat. Commun."},{"key":"2907_CR373","doi-asserted-by":"publisher","DOI":"10.1126\/sciimmunol.adt6616","volume":"10","author":"T Lazarov","year":"2025","unstructured":"Lazarov, T. et al. Characterization of the mammalian prodefinitive angio-hematopoietic lineage. Sci. Immunol. 10, eadt6616 (2025).","journal-title":"Sci. Immunol."},{"key":"2907_CR374","doi-asserted-by":"publisher","first-page":"755","DOI":"10.1016\/j.immuni.2016.02.017","volume":"44","author":"L van de Laar","year":"2016","unstructured":"van de Laar, L. et al. Yolk sac macrophages, fetal liver, and adult monocytes can colonize an empty niche and develop into functional tissue-resident macrophages. Immunity 44, 755\u2013768 (2016).","journal-title":"Immunity"},{"key":"2907_CR375","doi-asserted-by":"publisher","first-page":"1312","DOI":"10.1016\/j.cell.2014.11.018","volume":"159","author":"Y Lavin","year":"2014","unstructured":"Lavin, Y. et al. Tissue-resident macrophage enhancer landscapes are shaped by the local microenvironment. Cell 159, 1312\u20131326 (2014).","journal-title":"Cell"},{"key":"2907_CR376","doi-asserted-by":"publisher","first-page":"1327","DOI":"10.1016\/j.cell.2014.11.023","volume":"159","author":"D Gosselin","year":"2014","unstructured":"Gosselin, D. et al. Environment drives selection and function of enhancers controlling tissue-specific macrophage identities. Cell 159, 1327\u20131340 (2014).","journal-title":"Cell"},{"key":"2907_CR377","doi-asserted-by":"publisher","first-page":"655","DOI":"10.1016\/j.immuni.2019.09.002","volume":"51","author":"M Sakai","year":"2019","unstructured":"Sakai, M. et al. Liver-derived signals sequentially reprogram myeloid enhancers to initiate and maintain Kupffer cell identity. Immunity 51, 655\u2013670.e8 (2019).","journal-title":"Immunity"},{"key":"2907_CR378","doi-asserted-by":"publisher","first-page":"1170","DOI":"10.1016\/j.neuron.2018.05.014","volume":"98","author":"FC Bennett","year":"2018","unstructured":"Bennett, F. C. et al. A Combination of ontogeny and CNS environment establishes microglial identity. Neuron 98, 1170\u20131183.e8 (2018).","journal-title":"Neuron"},{"key":"2907_CR379","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-020-18287-x","volume":"11","author":"T Weinberger","year":"2020","unstructured":"Weinberger, T. et al. Ontogeny of arterial macrophages defines their functions in homeostasis and inflammation. Nat. Commun. 11, 4549 (2020).","journal-title":"Nat. Commun."},{"key":"2907_CR380","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-018-07548-5","volume":"9","author":"A Shemer","year":"2018","unstructured":"Shemer, A. et al. Engrafted parenchymal brain macrophages differ from microglia in transcriptome, chromatin landscape and response to challenge. Nat. Commun. 9, 5206 (2018).","journal-title":"Nat. Commun."},{"key":"2907_CR381","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1038\/s41590-019-0568-x","volume":"21","author":"H Aegerter","year":"2020","unstructured":"Aegerter, H. et al. Influenza-induced monocyte-derived alveolar macrophages confer prolonged antibacterial protection. Nat. Immunol. 21, 145\u2013157 (2020).","journal-title":"Nat. Immunol."},{"key":"2907_CR382","doi-asserted-by":"publisher","first-page":"1225","DOI":"10.1016\/j.immuni.2024.04.019","volume":"57","author":"S Trzebanski","year":"2024","unstructured":"Trzebanski, S. et al. Classical monocyte ontogeny dictates their functions and fates as tissue macrophages. Immunity 57, 1225\u20131242.e6 (2024).","journal-title":"Immunity"},{"key":"2907_CR383","doi-asserted-by":"publisher","DOI":"10.1186\/s40364-023-00537-x","volume":"11","author":"K Hadiloo","year":"2023","unstructured":"Hadiloo, K., Taremi, S., Heidari, M. & Esmaeilzadeh, A. The CAR macrophage cells, a novel generation of chimeric antigen-based approach against solid tumors. Biomark. Res. 11, 103 (2023).","journal-title":"Biomark. Res."},{"key":"2907_CR384","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1186\/s13046-022-02327-z","volume":"41","author":"K Pan","year":"2022","unstructured":"Pan, K. et al. CAR race to cancer immunotherapy: from CAR T, CAR NK to CAR macrophage therapy. J. Exp. Clin. Cancer Res. 41, 119 (2022).","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"2907_CR385","doi-asserted-by":"publisher","first-page":"1089","DOI":"10.1038\/s41423-024-01207-0","volume":"21","author":"L Peng","year":"2024","unstructured":"Peng, L., Sferruzza, G., Yang, L., Zhou, L. & Chen, S. CAR-T and CAR-NK as cellular cancer immunotherapy for solid tumors. Cell Mol. Immunol. 21, 1089\u20131108 (2024).","journal-title":"Cell Mol. Immunol."}],"container-title":["Signal Transduction and Targeted Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41392-026-02907-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41392-026-02907-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41392-026-02907-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T00:02:57Z","timestamp":1787011377000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41392-026-02907-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,18]]},"references-count":385,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["2907"],"URL":"https:\/\/doi.org\/10.1038\/s41392-026-02907-x","relation":{},"ISSN":["2059-3635"],"issn-type":[{"value":"2059-3635","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,18]]},"assertion":[{"value":"3 February 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 May 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 June 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 August 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"N.L. is the author of several patent applications in the context of iPSC-macrophage manufacturing and use of cells derived thereof. In addition, N.L. receives research funding from Novo Nordisk SA. K.H. and M.E. are employees of Evotec International GmbH and Evotec (UK) Ltd., respectively. All other authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Ethics"}}],"article-number":"331"}}